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 Of the three major cell types in bone, osteocytes are considered the major 
mechanosensors, capable of detecting whole-bone mechanical forces at a cellular level and 
coordinating tissue-level bone formation and resorption responses. The pathology of age-induced 
bone loss, a major factor in the development of osteoporosis, is attributed to impaired osteocyte 
mechanosensing. However, real-time evidence of immediate osteocyte responses to mechanical 
load to support the blunted tissue-level responses that have been demonstrated thus far is lacking. 
A ubiquitous cellular response upstream of many functions in all cell types, intracellular calcium 
(Ca2+) is an early mechanosensitive signal in osteocytes, wherein the response characteristics 
studied in systems of multiple scales are related to mechanical stimuli. Thus, this phenomenon 
can be characterized as a real-time measure of osteocyte mechanosensitivity. The objective of 
this thesis was to utilize an ex vivo model of osteocyte Ca2+ signaling to investigate potentially 
altered mechanosensitivity of the osteocyte network in two clinical contexts: aging, and a 
recently-approved therapy for treatment of osteoporosis. Additionally, we aimed to enhance this 
ex vivo model to identify a functional consequence of this robust Ca2+ signaling response to 
mechanical load in the context of osteocyte mechanotransduction. 
 We first sought to characterize and compare Ca2+ signaling responses to mechanical load 
in osteocytes from aged and young-adult mice using an ex vivo model to visualize cell networks 
in viable mouse tibiae. We found that fewer osteocytes responded to whole-bone cyclic 
mechanical loading in aged mice tibiae compared to those from young-adult mice and did so in a 
 
 
delayed manner, suggesting a diminished mechanosensitivity to load. Osteocytes from aged mice 
also lacked the well-correlated relationship between Ca2+ signaling synchrony and cell-cell 
distance exhibited by young-adult osteocyte networks. Taken together, we have demonstrated, 
for the first time, a real-time measure of the dampened mechanosensing and lack of signal 
coordination in aged osteocyte networks in situ, which may contribute to blunted long-term bone 
formation responses to load. 
 Next, we utilized the ex vivo Ca2+ signaling model to investigate the effect of bone 
formation in response to treatment with sclerostin antibody (Scl-Ab) on osteocyte 
mechanosensing. Previous studies have identified two phases of bone formation response to Scl-
Ab treatment: an initial period of rapid bone formation with short-term dosing and a return to a 
steady phase of bone formation response with long-term dosing. Thus, we treated mice according 
to three groups: vehicle, short-term Scl-Ab, and long-term Scl-Ab. Serum P1NP assays and 
biweekly micro-CT scans throughout the treatment period confirmed the two phases of bone 
formation response to Scl-Ab. At the conclusion of treatment, under ex vivo whole-bone loading 
matched at 10 N, there were no significant differences in osteocyte Ca2+ signaling parameters 
between treatment groups. However, under strain-matched loading, fewer osteocytes from the 
short-term group exhibited Ca2+ responses and the initiation of Ca2+ signaling was delayed. We 
interpreted this as reduced mechanosensing in osteocytes that have been newly-embedded in 
bone that has been rapidly formed in response to Scl-Ab, as confirmed by alizarin red intensity 
analysis in the osteocyte field of view ex vivo. This study provides real-time evidence of the 
cellular responses under the distinct phases of bone formation response to Scl-Ab and 
demonstrates that osteocyte mechanosensing is maintained with long-term treatment, suggesting 
that other mechanisms may be responsible for self-regulation of bone formation. 
 
 
 Given the robust Ca2+ responses to load characterized in osteocytes by our group and 
others, we concluded this work by investigating a consequence of this mechanism that may 
contribute to osteocyte mechanotransduction. A common Ca2+-dependent mechanism that has 
been demonstrated in osteocytes in vitro with possible implications for cell-cell communication 
is contraction of the actin cytoskeleton. Therefore, we sought to confirm this mechanism in 
osteocytes maintained in their native 3D network and morphology using the ex vivo murine tibia 
model. We successfully enhanced the model to simultaneously image intracellular Ca2+ and the 
F-actin network of individual osteocytes in situ at high magnification using transgenic Lifeact 
mice paired with either Ca2+ dye or bred with Ca2+ indicator mice. In both models, using 
biochemical stimuli, we quantified actin network dynamics over time and identified Ca2+-
dependent contractile events. Under mechanical loading, phasic actin network contractions 
corresponded to individual Ca2+ peaks in single osteocytes. The mechanosensitive nature of these 
contractions was demonstrated by comparing cellular dynamics in single cells under two paired 
mechanical loading levels; interestingly, mechanosensitivity was dependent on the order of 
application of these load magnitudes. In identifying this novel mechanosensitive Ca2+-dependent 
mechanism, we enhance the understanding of the mechanotransduction pathway in osteocytes 
and have provided a potential point of intervention in cases where osteocyte 
mechanotransduction is inhibited, such as in osteoporosis. 
 Taken together, this body of work contributes to knowledge of how osteocytes are 
sensing mechanical forces in different contexts and transducing signals to effector cells. We 
provide novel, real-time, immediate measures of osteocyte mechanosensing in situ that may 
correspond to whole-bone responses, such as age-induced bone loss or the differential responses 
to Scl-Ab treatment. Future work will focus on ways to recover diminished osteocyte 
 
 
mechanosensing and further connect the cell responses we observe herein to long-term bone 
formation responses in clinical applications. 
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Chapter 1: Introduction 
 
1.1 Background 
1.1.1 Cellular contributions to bone adaptation 
 Bone is a dynamic tissue capable of structural adaptation in response to the application or 
absence of mechanical loads. This fundamental assumption in bone research was originally 
hypothesized by Julius Wolff in the 19th century, who claimed that bone architecture aligned 
with mechanical stress trajectories and would adjust to follow as such2. Indeed, the integrity of 
bone tissue is highly dependent on mechanical stimulation, as evidenced in extreme cases such 
as differential bone gain in athletes3, 4 and dramatic bone loss in situations of extended bedrest5 
or spaceflight6. These observations have motivated decades of research dedicated to the 
underlying cellular mechanisms contributing to this tissue response to varied mechanical loading 
environments in bone.  
The shape and structure of bone is maintained by three primary cell types (Figure 1.1). 
Osteoblasts are cells of a mesenchymal stem cell lineage and are responsible for the synthesis 
and mineralization of new bone matrix. Osteoclasts are a multi-nucleated, hematopoietic cell 
type which resorbs bone. The coupled and balanced activities of these two cell types occurring 
on specific sites of the same bone surface is referred to as remodeling. Bone resorption and 
formation can also occur in an uncoupled manner and on separate surfaces to shape bone, known 
as modeling7. The third cell type, which has emerged as a critical cell type for mechanically-
directed bone modeling and remodeling, is the osteocyte. 
Osteocytes are derived from terminally-differentiated osteoblasts which become 
embedded in the bone matrix they produce. They are long-lived, dendritic cells which comprise 
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95% of all bone cells, speaking to their intransience8. Osteocytes are embedded throughout the 
mineralized bone matrix in an extensive interconnected network of channels known as the 
lacunar-canalicular system (LCS)9. The function of these cells was previously unknown or even 
considered to be inert. Unlike osteoblasts and osteoclasts found on bone surfaces, the location of 
osteocytes deep within the bone matrix presents a challenge for isolation of primary cells for in 
vitro studies or visualization of native osteocytes in vivo. Fortunately, continued improvements 
in research techniques and technology have facilitated the study of osteocytes and their influence 
on bone adaptation. 
1.1.2 Osteocytes as mechanosensors 
Physiological mechanical loading of long bone along its long axis results in bending, 
inducing compressive and tensile strains on bone surfaces. The magnitudes of these strains in the 
human tibia present in the range of 237–1250 με during normal ambulation7, 10, and differences in 
strain magnitudes have been associated with differing degrees of bone adaptation11, 12. The shape, 
abundance, location, and connectivity of osteocytes prime them to detect these mechanical strains 
(Figure 1.2), but the exact mechanism by which they do so is unclear. It is most widely accepted 
that bending of bone creates pressure gradients within the LCS that drive interstitial fluid flow and 
create fluid shear stresses on the osteocyte cell membrane13-16. Indeed, this phenomenon has been 
quantified experimentally 17-19, lending further support to LCS fluid flow as the means of 
transduction of mechanical forces applied to the bone into a local mechanical signal perceived by 
osteocytes. 
Osteocytes can translate changes in mechanical loading to an overall adaptive response in 
the form of bone modeling or remodeling. The most striking evidence of this comes from a 
transgenic mouse model of targeted ablation of osteocytes, in which mice were resistant to 
3 
 
unloading-induced bone loss20. It has also been established that mechanical loading and unloading 
influence osteocyte production of sclerostin21, a negative regulator of the bone-forming 
osteoblasts, and receptor activator of nuclear factor κB ligand (RANKL)22, 23, which activates 
bone-resorbing osteoclasts. Furthermore, these changes in protein production are highly correlated 
with sites of anabolic bone formation in response to prescribed mechanical loading in whole 
bones21, 24-26. Still, the immediate, intracellular mechanotransduction mechanisms in osteocytes 
which influence long-term, downstream adaptive responses remain unclear. 
1.1.3 Altered mechanotransduction in clinical contexts 
The ability of osteocytes to sense and translate mechanical loads can change depending on 
a variety of factors. For instance, as humans age, the osteocyte network degrades, as demonstrated 
by a reduction in osteocyte dendrite number and cell density27. This degeneration of osteocyte 
morphology and network characteristics is believed to influence osteocyte mechanosensing. For 
example, in contrast to sclerostin down-regulation that is typically seen with loading in younger 
mice21, 25, osteocytes in aged mice show persistent expression of sclerostin under mechanical 
loading28. This diminished ability to translate mechanical loads through relevant protein 
production could explain the diminished osteogenic response to load in older mice that has been 
demonstrated by several groups11, 29, 30.  Nevertheless, real-time data of the aged osteocyte 
network’s ability to respond to mechanical load is lacking. 
Decline in bone mass with age ultimately presents itself as osteoporosis, a disease that 
resulted in more than 2 million osteoporotic fractures in the United States in 201531. One 
treatment for osteoporosis approved by the U.S. Food and Drug Administration in 2019 utilizes 
an antibody targeting sclerostin, the protein primarily produced by osteocytes to inhibit 
osteoblast activity and bone formation. Treatment with antibodies to sclerostin (Scl-Ab) in 
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preclinical animal models results in increased bone formation and decreased bone resorption32, 
ultimately leading to a rapid increase in bone mass, bone mineral density (BMD) and bone 
strength. In clinical trials, Scl-Ab has been shown to rapidly increase bone mineral density and 
decrease the incidence of osteoporotic fractures33, 34. However, the effects of this treatment have 
also been shown to be dampened with repeated, long-term administration in both animal and 
human studies35-37. It is hypothesized that the altered mechanical environment of the bone due to 
increased bone formation may be influencing the osteocyte ability to respond to load, but there is 
no evidence of this to date. 
1.1.4 Calcium signaling in osteocytes 
Bone cells respond to physical stimuli with numerous biochemical signaling events, one of 
the earliest being a peak in intracellular calcium (Ca2+) 38, 39. This response was first demonstrated 
in osteoblasts but has also been characterized in osteoclasts and their hematopoietic precursors40, 
41. Interestingly, the characteristics of Ca2+ signaling in osteoblast-like cells have been shown to 
be dependent upon fluid flow profile, mechanical loading frequency, and magnitude of shear 
stress42, 43. This prompted the investigation of Ca2+ signaling in osteocytes in an effort to elucidate 
potential mechanotransduction mechanisms.  
Early studies of Ca2+ signaling in osteocytes relied on mechanical stimulation of single 
cells. In one particular model, a localized mechanical stimulus was applied to a single osteocyte 
using a glass microneedle, which induced site-specific calcium responses between the cell 
processes and cell body44. Studies utilizing fluid flow stimulation show changes in intracellular 
Ca2+ that are well-correlated with individual cell strain45. Experimental procedures have since 
shifted to utilizing osteocyte cell networks to recapitulate in vivo configuration and connectivity. 
Osteocytes in micropatterned networks show highly repetitive spike-like Ca2+ peaks under fluid 
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flow stimulation, which are sustained throughout the entire stimulation period. These osteocyte 
networks are more sensitive to fluid flow stimulation than similarly-formed networks of 
osteoblasts46, and the Ca2+ responses are more pronounced under steady than oscillatory flow47. 
Similar means have been used to investigate the intracellular mechanisms underlying the initiation 
and sustainment of these Ca2+ oscillations under fluid flow48. 
Since osteocytes regulate bone remodeling by sensing the micromechanical environment 
induced by bone matrix deformation, it is favorable to study potential mechanosensing 
mechanisms in conditions that are as close to in situ as possible49. Many studies have utilized ex 
vivo whole-bone models of osteocyte mechanosensing, which maintain the stellate morphology 
of the osteocyte network in its surrounding native bone matrix. These models are used in 
combination with fluorescent microscopy techniques to observe the real-time Ca2+ response of 
bone cells to mechanical stimuli, including bone matrix deformation50 and fluid shear over bone 
fragments51. One model in particular was developed to confirm the differences in Ca2+ signaling 
between osteocyte and osteoblast networks, demonstrating that native osteocytes within the bone 
matrix exhibit robust Ca2+ oscillations in response to physiological whole-bone loading, which 
are more robust than under autonomous conditions and more distinct than those of osteoblast 
cells on the bone surface19. These load-induced Ca2+ oscillations presented the same peak 
characteristics as previously observed in in vitro osteocytes under fluid flow46-48, confirming this 
phenomenon in native osteocytes. Additionally, the responsive characteristics of osteocytes are 
enhanced with increasing mechanical load magnitude, presenting a real-time measure of 





Ca2+ signaling as an indicator of real-time osteocyte mechanosensitivity has yet to be 
translated to clinical contexts, such as in aging or osteoporosis treatment. Such a robust response 
in what is considered to be the primary mechanosensitive cell type in bone has the potential to 
uncover factors contributing to altered bone formation responses in these cases. Additionally, 
while Ca2+ oscillations in osteocyte networks have been confirmed in experimental systems of 
multiple scales, the exact function of this immediate response to load remains unclear. 
Specifically, the downstream consequences of Ca2+ signaling of osteocytes in their native bone 
matrix have yet to be observed and characterized, as well the mechanosensitive potential of these 
downstream functions.  
 
1.3 Aims and Organization 
The goal of this work is to enhance understanding of osteocyte mechanotransduction and 
how osteocyte mechanosensitivity may be altered in contexts related to bone disease pathologies. 
The studies presented in this thesis are based on an ex vivo murine tibia model of real-time 
osteocyte Ca2+ signaling in response to whole bone loading (Figure 1.3)19.  
In the first study presented in Chapter 2, we utilized the mechanosensitive properties of 
Ca2+ signaling in the osteocyte network to determine the effect of age on osteocyte 
mechanotransduction by comparing responses to mechanical load between young-adult mice and 
aged mice. We hypothesized that a loss of mechanosensitivity in the osteocyte network will be 
exhibited by a reduction in Ca2+ signaling responses under whole-bone mechanical loading of 
tibia from aged mice. This hypothesis was explored through the following aim: 
Specific Aim 1: Characterize and compare real-time Ca2+ signaling profiles of the ex vivo 
osteocyte network from mature adult and old mice in response to mechanical loading. 
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In the next study presented in Chapter 3, osteocyte mechanosensitivity was further 
investigated in the context of Scl-Ab treatment, which has recently been approved as a new 
therapy for osteoporosis. We hypothesized that bone formation responses to long-term treatment 
with Scl-Ab diminishes the Ca2+ signaling response in ex vivo osteocytes to mechanical load due 
to the alteration of the mechanical environment. Osteocyte mechanosensitivity was characterized 
in tibiae from mice treated with Scl-Ab or vehicle through the following Specific Aims: 
Specific Aim 2a: Compare real-time Ca2+ signaling profiles under load-matched 
mechanical stimulation of ex vivo osteocytes from mice that received either short- or 
long-term treatment with Scl-Ab or vehicle. 
 
Specific Aim 2b: Compare real-time Ca2+ signaling profiles under strain-matched 
mechanical stimulation of ex vivo osteocytes from mice that received either short- or 
long-term treatment with Scl-Ab or vehicle. 
 
In Chapter 4, we investigated the functional consequences of load-induced Ca2+ 
oscillations in osteocytes by expanding upon the established ex vivo model to quantify 
intracellular actin network dynamics. We hypothesized that osteocytes exhibit Ca2+-dependent 
actomyosin contractions in their native bone matrix in response to mechanical loading, and that 
these contractions also demonstrate mechanosensitive properties. The work in this chapter was 
guided by the following Specific Aims: 
Specific Aim 3a: Simultaneously image real-time Ca2+ and actin network dynamics of 
live osteocytes in their native bone matrix in response to biochemical and mechanical 
stimuli using an ex vivo murine tibiae model. 
 
Specific Aim 3b: Quantify Ca2+-dependent actomyosin contractions in ex vivo osteocytes 
in response to different magnitudes of physiological mechanical loading of whole tibiae. 
 
Chapter 5 summarizes the conclusions of these studies, suggests future work to expand 








Figure 1.1 Major cell types in bone. The resorption and formation of bone is spatially and 
temporally coordinated by three major cell types. Osteoclasts are derived from hematopoietic 
stem cells which differentiate and fuse into multi-nucleated bone-resorbing cells. Bone is 
synthesized and mineralized by osteoblasts either in concert with (remodeling) or distinct from 
resorption (modeling). A proportion of mature osteoblasts further differentiates into osteocytes as 
they become embedded in the bone matrix they produce. Osteoblast and osteoclast activity are 
influenced by osteocyte production of sclerostin and RANKL, respectively. Given their role in 
transducing mechanical stimuli to promote bone formation and resorption processes, osteocytes 
are considered the primary mechanosensory cell type in bone. Image credit: Riddle RC, Clemens 
TL. Bone Cell Bioenergetics and Skeletal Energy Homeostasis. Physiol Rev. Apr 





Figure 1.2 Scanning electron micrograph of an osteocyte in resin. Osteocytes exist as stellate 
cells embedded in the bone matrix, interconnected throughout the tissue via extensive dendritic 




Figure 1.3 Ex vivo model of osteocyte Ca2+ signaling. A. Mouse tibiae are dissected and 
transferred to a custom mechanical loading system, where cyclic compressive loads are applied 
to the distal end of the whole bone while live osteocytes are imaged using confocal microscopy. 
B. The intracellular Ca2+ indicator Fluo-8 AM is incubated with tibia samples to allow for 
imaging of Ca2+ dynamics in live osteocytes over time in response to mechanical and 
biochemical stimuli. C. Fluo-8 intensity is normalized to baseline intensity and plotted over time 
for individual osteocytes (B, red oval). Peaks in intracellular Ca2+ are identified and 








Aging is one of the most important factors in determining the likelihood of developing 
osteoporosis52, 53, a systemic disease characterized by low bone mass and microarchitectural 
deterioration of bone tissue with a consequent increase in bone fragility and susceptibility to 
fracture. Age-related changes in bone include trabecular perforation, thinning, and loss of 
connectivity, as well as cortical thinning and increased porosity54, along with possible changes in 
the bone composition itself55. Osteoporotic reduction in skeletal mass is caused by an imbalance 
between bone resorption and bone formation53, hinting at dysfunction of how osteocytes direct 
remodeling processes. 
At the cellular level, it has been shown that aging adversely affects the integrity and 
morphology of the mechanosensing osteocyte network56. Methods such as acid-etching and 
scanning electron microscopy of resin-embedded bone reveals lower lacunar density and a 
reduction in canaliculi per lacuna within the bone matrix in both aged animals57 and humans27, 58, 
suggesting degradation of the connectivity of the cellular network. Most recently, confocal 
imaging modalities have allowed for comprehensive analysis of osteocyte cell morphology 
directly59, in addition to properties of the lacunar-canalicular system (LCS) in which the cells 
reside60. Multiplexed-3D-confocal imaging of murine osteocytes reveals a dramatic reduction in 
osteocyte dendrite number and cell density, particularly in female mice where osteocyte 
dendricity decreases linearly with age and correlates significantly with cortical bone changes59. 
Given the crucial role of the osteocyte network in sensing and translating mechanical loads, it is 
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plausible that diminished connectivity of this cellular network could adversely affect short-term 
mechanotransduction processes driving long-term bone adaptation. 
Impaired osteocyte sensitivity with age has been most commonly demonstrated in tissue-
level analyses of bone formation in response to mechanical load. Micro-computed tomography 
(micro-CT) analysis reveals a suppression of the typical osteogenic response to mechanical 
loading, albeit still present, demonstrated by a greater accrual of cortical bone in young-adult 
compared to aged mice61-63. Early histomorphometry data suggests this suppressed response 
corroborates with reduced periosteal bone formation rate and bone forming surfaces in aged 
turkeys29 and rats30 compared to younger animals. In mice, this periosteal bone formation rate is 
65-70% lower in old animals compared to young-adult animals loaded at equivalent peak 
strain61.  At a cellular level, the reduced bone formation response of aged mice to loading may be 
due to the inability of aged osteocytes to sustain Wnt activity, which is required for optimal bone 
formation induced by repeated loading28. While these studies provide evidence for long-term 
effects of aging on tissue-level responses to mechanical loading, it is still unclear how aging 
directly affects the osteocyte network ability to immediately sense and transduce mechanical 
loads to influence long-term responses. 
Early in vitro cell studies investigating bone cell responsiveness utilized human bone cell 
cultures from aged, osteoporotic donors. These studies focused on early release of prostaglandin 
E2 (PGE2), prostaglandin I2 (PGI2), nitric oxide, and transforming growth factor-beta (TGF-
beta) in response to pulsating fluid flow and showed little to no effect of age on these 
responses64, 65. Another early biological response to physical stimuli in bone cells is a peak in 
intracellular calcium (Ca2+)38, of which age has been shown to have a diminishing effect in rat 
osteoblastic cells42. However, the mechanosensitive potential of early Ca2+ responses in aged 
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osteocytes has yet to be investigated. Indeed, it has been shown that osteocyte networks in vitro 
demonstrate highly repetitive spike-like Ca2+ peaks under fluid flow stimulation, which are 
dramatically different from those in osteoblastic networks46. Recapitulating this phenomenon at a 
tissue-level scale, native osteocytes exhibit robust Ca2+ oscillations in response to physiological 
whole-bone loading, which are enhanced with increasing mechanical load magnitude and thus 
serve as a real-time measure of osteocyte mechanosensitivity in situ in response to whole bone 
mechanical loading19. Therefore, we hypothesize that impairment of mechanosensitivity in the 
aged osteocyte network will be exhibited by diminished Ca2+ signaling responses under 
mechanical loading, much akin to the age-related blunted protein expression and subsequent 
dampened bone formation responses shown by other groups. 
 
2.2 Materials and Methods 
2.2.1 Aged and young-adult mice 
Female C57BL/6JN inbred mice at 5 and 22 months of age, corresponding to young-adult 
and old age in humans, respectively 66, were purchased from the National Institute of Aging aged 
rodent colony (NIA, Bethesda, MD, USA) managed by Charles River Laboratories (Wilmington, 
MA, USA) in collaboration with Dr. Matthew J. Silva (Department of Orthopaedic Surgery, 
Musculoskeletal Research Center, Washington University, St. Louis, MO, USA). Animals were 
housed 3-5 per cage and given access to food and water ad libitum (PicoLab 5053 and 5058, 
LabDiet, St. Louis, MO, USA). All animal procedures were approved by the Institutional 
Animal Care and Use Committee at Columbia University in accordance with Institute for 
Comparative Medicine and national guidelines. 
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2.2.2 Osteocyte intracellular Ca2+ imaging 
 Mice were sacrificed by CO2 inhalation and bilateral tibiae were immediately dissected 
under sterile conditions. Tibiae were maintained in supplemented cell culture media (αMEM + 
5% calf serum, 5% defined fetal bovine serum) and incubated at 37°C, 5% CO2 for 2 hours. 
Tibia samples were then incubated with Ca2+ indicator Fluo-8 AM (AAT Bioquest, Sunnyvale, 
CA, USA) dissolved in 20% Pluronic F-127 in DMSO (Invitrogen, Carlsbad, CA, USA) for 45-
60 minutes, washed, and post-incubated for 10 minutes before being transferred to a custom 
mechanical loading device for simultaneous loading and imaging. For experiments using 5-
month-old and 22-month-old Dmp1-Cre;Ai38flx/flx  mice, which inherently express the GCaMP3 
Ca2+ indicator in osteocytes, tibiae were similarly dissected and maintained in supplemented 
media before being immediately placed in the custom mechanical loading device. 
Using an Olympus FluoView FV1000 laser scanning confocal microscope with a 10x 
objective (Olympus, Waltham, MA, USA), Fluo-8 AM-dyed or GCaMP3-expressing 
osteocytes were visualized 20-30 µm below the anteromedial cortical bone surface of either 
the right or left tibiae, depending on baseline signals in the cells. Ca2+ indicators were excited 
at 473 nm and fluorescence emissions were collected at 520 nm. Kalman filtering was applied 
during imaging with an acquisition time of 2.218 s/frame. Depending on the distribution of 
Fluo-8 AM dye-loading and baseline cell signals, time-lapse images were recorded for n=6-8 
tibiae/age group (Table 2.1). For Dmp1-Cre;Ai38flx/flx mice, images were recorded for 5 
tibiae/age group. 
2.2.3 Whole-bone mechanical loading 
Confocal time-lapse images were synchronized with a rest-inserted mechanical loading 
protocol to eliminate out-of-focus motion artifacts resulting from deformation of the bone 
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sample, with images being acquired every 5 seconds for 900 seconds total19. Five baseline 
images were acquired before mechanical loading was initiated via a trigger from the 
FluoView software to a 16-bit data acquisition (DAQ) card (NI USB-6210) and LabView VI 
(National Instruments, Austin, TX, USA). Samples were maintained in supplemented cell culture 
media while cyclic mechanical loads were applied along the long axis of the whole bone using a 
custom-designed system19. A pre-load of 2 N was applied, followed by cyclic axial loading of 1 
Hz triangle waveforms with 4 s rest-insertion after each cycle to allow for confocal image 
acquisition. Load magnitudes of 10.2 N and 8.3 N were applied to the 5-month-old and 22-
month-old tibiae respectively, corresponding to anteromedial surface strain of 1500 µƐ67.  
2.2.4 Osteocyte image analysis 
Translation motion artifacts were removed using the StackReg image registration 
algorithm in ImageJ (U.S. National Institutes of Health; Bethesda, MD, USA). Cell bodies were 
manually traced using MetaMorph 7.0 (Molecular Devices, Downingtown, PA, USA), and the 
average Ca2+ indicator intensity of the cell body was extracted as a function of time. Using 
MATLAB 2014b (The MathWorks, Natick, MA, USA), the average pixel intensity of each 
individual cell was normalized by the average of corresponding baseline frames, and a Ca2+ peak 
was identified as a transient increase to 3 times the standard deviation of baseline intensity of 
each cell. The percentage of responsive cells (> 1 peak) of all Fluo-8 AM-dyed or GCaMP3-
expressing cells, average number of Ca2+ peaks exhibited by responsive cells, average Ca2+ peak 
magnitude, and average time to the first Ca2+ peak following initiation of mechanical loading 
were quantified for each tibia sample19, 46, 47. Ca2+ signaling in two osteocytes was considered 
synchronous if the time between the any of the peaks from each cell was less than 15 seconds68. 
Synchrony between cells was evaluated in a pair-wise manner for all cells in the field of view 
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(FOV). The number of synchronous cell pairs was normalized by all cell pairs in the FOV for 
each tibia sample. 
2.2.6 Osteocyte network visualization 
Tibia samples from 5-month-old and 22-month-old mice were fixed in 10% formalin for 
48 hours before being transferred to 70% ethanol (n=5/group). Samples were then incubated with 
100 µM Vybrant DiI (Thermo Fisher Scientific, Waltham, MA, USA) in 100% ethanol for 24 
hours before imaging with confocal microscopy 69. Images of the stained osteocyte cell 
membranes were taken in the approximate region of ex vivo osteocyte Ca2+ signalling, 20-30 µm 
below the anteromedial bone surface using confocal microscopy. 
2.2.5 Micro-computed tomography scanning and analyses 
Cortical bone morphological parameters of ex vivo frozen tibia samples were assessed via 
micro-computed tomography (micro-CT) using a Scanco VivaCT 80 system (Scanco Medical 
AG, Brüttisellen, Switzerland). Scanning parameters were 55 kVp energy, 109 µA intensity, and 
300 ms integration time; reconstructed images had 5.0 µm isotropic voxel size. Prior to all 
analyses, a Gaussian filter was applied (sigma = 0.8, support = 1) to reduce noise. The cortical 
region of interest was set at 2.0 mm in length, centered midway between the tibial plateau and 
the distal tibiofibular junction. Global thresholds of 40% of the maximum gray scale value were 
used to classify cortical bone. Standard Scanco evaluation software was used to calculate cortical 
thickness (Ct.Th) in a subset of the experimental C57BL/6N mice tibia samples (n=4-5/group). 
2.2.7 Statistics 
All data are presented as mean ± standard deviation. Student’s t-test was used to 
determine significant differences in cortical thickness, osteocyte responsive percentage, Ca2+ 
peak number, Ca2+ peak magnitude, and time to 1st peak between samples from 5-month-old and 
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22-month-old mice. To determine the correlation between synchronous cell pair number and 




2.3.1 Age-related changes in ex vivo mouse tibiae  
22-month-old mice exhibited age-related bone loss as shown by micro-CT imaging of the 
cortical bone (Figure 2.1 A). Aged mice had significantly thinner cortical bone (0.102 ± 0.003 
mm) compared to young-adult 5-month-old mice (0.151 ± 0.019 mm) at the time of sacrifice for 
Ca2+ imaging experiments (Figure 2.1 B). Fixed osteocyte networks of aged mice exhibited a 
lower cell density and diminished dendricity compared to networks of young-adult mice, 
suggesting compromised connectivity (Figure 2.2). 
2.3.2 Ca2+ signaling is diminished in osteocytes of aged mice during tibial loading 
Time-lapse Ca2+ signaling analysis was performed for 362 and 182 individual osteocytes 
dyed with Fluo-8 AM from 5-month-old and 22-month-old mice tibiae, respectively (Table 2.1). 
In 5-month-old mice, 34.6 ± 9.9% of osteocytes responded to mechanical loading with an 
average of 3.1 ± 0.9 Ca2+ peaks per responsive cell in the 900 s loading/imaging period. In 22-
month-old mice, the percentage of responsive cells decreased significantly to 13.6 ± 5.0% of 
cells in the FOV (Figure 2.3, Figure 2.4 A).  Despite few responding cells in the aged mice 
samples, the average number and intensity of Ca2+ peaks in response to mechanical load were not 
significantly different between age groups (Figure 2.4 B, C). Ca2+ signaling characteristics were 
comparable between Dmp1-Cre;Ai38flx/flx osteocytes and age-matched Fluo-8 AM-dyed 
osteocytes under the same loading conditions (Figure 2.5). 
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2.3.3 Osteocyte networks from aged mice lack coordination of Ca2+ signaling between cell pairs 
In young-adult mice, responding cells initiated Ca2+ signaling 163.6 ± 72.3 seconds 
following loading initiation. By comparison, the initiation of Ca2+ signaling was delayed 
significantly in the osteocytes of aged mice (Figure 2.3, Figure 2.4 D), with the first Ca2+ peak 
occurring 326.7 ± 113.9 seconds following the start of cyclic mechanical loading. Synchrony 
analysis of Ca2+ signaling between all cell pairs in the FOV revealed a strong negative 
correlation (R2=0.97) between cell-cell distance and number of synchronous cell pairs in 5-
month-old osteocytes (Figure 2.6). This correlation was absent in 22-month-old osteocyte 
networks, with fewer total synchronous cell pairs (10 pairs) compared to 5-month-old osteocyte 
networks (442 pairs). 
 
2.4 Discussion 
The study of osteocytes in explanted bone tissue models allows for preservation of the 
native 3D network and connectivity, which are both unique and functionally relevant to this 
mechanosensing cell type. The nature of the intracellular osteocyte network can be influenced by 
mechanical environments70 and disease pathologies. For instance, osteocyte connectivity is 
shown to be compromised with aging 59, which we observed in our own samples via cell 
membrane staining in fixed tibiae. The ex vivo model of osteocyte Ca2+ signaling allows us to 
directly study live cells in their native networks in whole-bone samples from animals affected by 
age-related bone loss, as confirmed by micro-CT. Thinning of the cortical bone with age 
motivated our selection of strain-matched mechanical load levels between age groups67, such that 
the biological effects of aging on osteocyte network mechanosensitivity were captured rather 
than the effect of disparities in mechanical environment due to age-induced bone loss. 
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Additionally, the study of cortical osteocytes allowed us to capture mechanosensitive Ca2+ 
signaling in strain-matched areas, as opposed to in trabecular bone, where experimentally 
determining the mechanical loading environment proves to be challenging61.  
This study is the first to compare real-time mechanosensitive Ca2+ signaling in osteocyte 
networks from young-adult and old mice. Mechanosensing in the osteocyte network of aged 
mice was diminished to a significantly lower percentage of responsive cells while characteristics 
of the peaks themselves, particularly average peak number and average peak intensity, were 
consistent with those exhibited by osteocytes from young-adult mice. This implies that though 
there are fewer osteocytes sensitive to the prescribed anteromedial cortical bone strain in aged 
networks, these cells are responding in a manner comparable to young-adult osteocytes. It is 
possible that the low number of Fluo-8 dyed osteocytes, nearly half that of 5-month-old mice, is 
a direct result of the low osteocyte density of old mice. It is also feasible that age-related changes 
in metabolic processes may have affected Fluo-8 dye uptake between young-adult and aged 
mice. To address this, we also compared Ca2+ responses to mechanical load in osteocytes from 
young-adult and old Dmp1-Cre;Ai38flx/flx mice, which inherently express the Ca2+ indicator 
GCaMP3 in osteocytes 71, 72. This data confirms our age-related, Fluo-8 AM-based observations 
in a mouse model that does not require further manipulation beyond dissection 73. Taken 
together, our signaling data is in agreement with previous work suggesting that that there is a 
partial, but not complete loss of cortical mechanoresponsiveness with aging 62 
In a prior study of Ca2+ oscillations in aged bone cells, Donahue and colleagues 
demonstrated that osteoblastic cells isolated from old rats were less responsive to fluid flow in 
with a lower percentage of responsive cells, while the magnitude of fluid flow-induced Ca2+ 
oscillations was not significantly affected by age42. Our findings are consistent with these results 
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in that osteocyte networks from 22-month-old mice yield a lower percentage of responsive cells 
with a magnitude of responses not significantly different from that of 5-month-old mice. While 
the stimulus for mechanosensation in both studies is fluid flow, the current study utilizes axial 
whole-bone mechanical loading to induce physiological fluid flow in the LCS. Additionally, one 
key advantage of our study is our ability to study the responses of primary osteocytes in situ 
where the unique morphology of individual osteocytes and their extensive intercellular network 
are maintained. Indeed, this intercellular connectivity has been shown to have implications in 
mechanoresponsiveness to mechanical loading and signal transduction by work investigating the 
role of gap junction channel proteins in bone mechanostransduction74. 
In analyzing the characteristics of the Ca2+ peaks from individual osteocytes, we 
uncovered a delay in initiation of Ca2+ signaling in 22-month-old mice, suggesting an apparent 
randomness in Ca2+ responses of aged osteocytes. This motivated us to further investigate the 
synchrony of Ca2+ signaling between osteocytes in their native networks.. Micro-patterned 
MLO-Y4 cell networks in vitro have been shown to demonstrate high spatial intercellular 
synchronicity of Ca2+ oscillations in response to fluid flow, which is negatively correlated with 
intercellular distance68. Indeed, synchronous cell pair number decreased linearly with increasing 
cell-cell distance in osteocyte networks in 5-month-old mice tibiae. However, in old mice, our 
findings show that osteocyte networks exhibit an impaired ability to generate coordinated Ca2+ 
signaling. Reduction in osteocyte dendricity and cell density with age, particularly in females59, 
may be responsible for the lack of intercellular signaling coordination. Notably, there were more 
osteocytes within the field of view available for analysis in 5-month-old versus 22-month-old 
mice, an observation that limits our study of cell-cell synchrony and warrants further 
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investigation. To account for this absolute difference, the number of responsive cells was 
normalized to all cells in a field of view for each tibia sample.  
Future studies investigating rescue or enhancement of Ca2+ signaling in aged osteocyte 
networks will provide further insight to the mechanisms that are responsible for the diminished 
mechanosensing that we observe. Previous work has demonstrated the dominant role of ATP in 
mediating intercellular Ca2+ propagation from a single nanoindented bone cell to neighboring 
cells in a micropatterned network 75, 76, as well as intracellularly from the osteocyte process to the 
cell body 77. Furthermore, inhibition of the ATP-related signaling pathway reduces the number of 
Ca2+ oscillations as well as the percentage of osteocytes responding to mechanical stimulation 19, 
46, 78. Therefore, agonists for receptors for the purnergic pathway may enhance ATP diffusion 
between neighboring cells in the osteocytic network and may promote spatial intercellular 
coordination of Ca2+ events in aged osteocytes. However, if age-related degradation of the 
osteocyte network is indeed responsible for diminished coordination of Ca2+ signaling in the 
osteocyte network, then agonists for pathways upstream of Ca2+ signaling may have little effect 
on cell-cell synchrony. In this case, future studies may then be best focused on the influence of 
osteocyte network integrity on Ca2+ responses to load. This could be achieved through 
overexpression of gap junction-related proteins, as with an osteocyte Cx43 overexpression model 
in which age-induced cortical bone changes were ameliorated by preserving osteocyte viability 
and maintaining bone formation 79. It also would be of interest to computationally model 
possible changes in the fluid flow of the LCS, considered to be the primary mechanical stimulus 






The primary goal of this study was to utilize intracellular Ca2+ signaling to investigate the 
mechanosensitive capabilities of osteocytes from young-adult and old mice. By comparing the 
peak characteristics of Ca2+ oscillations of osteocyte networks from young-adult and old mice 
under tibial loading, we uncovered that mechanosensing in the osteocyte network of aged mice is 
diminished to a smaller percentage of cells with similar signaling characteristics as young-adult 
mice. We also show that osteocyte networks of aged mice exhibit an impaired ability to generate 
coordinated Ca2+ signaling. This compromised mechanosensing has implications for downstream 
bone cell signaling and may ultimately influence long-term bone formation processes that are 







Table 2.1 Experimental tibia samples and osteocytes dyed with Fluo-8 AM for analysis. 
Ca2+ signaling in tibial osteocytes of 5-month-old (young-adult) and 22-month-old (aged) mice 
were analyzed under strain-matched loading conditions. The number of tibia samples and 
osteocytes analyzed depended on the success of Fluo-8 intracellular Ca2+ dye-loading and 







Figure 2.1 Age-induced changes in cortical bone of old mice. A. Representative ex vivo 
micro-CT cross sections of tibial cortical bone in 5-month-old and 22-month-old female mice 
show decreased cortical thickness (Ct.Th) in the aged mice compared to young-adult. B. Average 
Ct.Th was calculated for the aged (n=4) and young-adult (n=5) tibia samples. Data are mean ± 





Figure 2.2 Age-induced changes in osteocyte network morphology. Fixed ex vivo osteocyte 
membranes are stained with DiI and imaged with confocal microscopy. Representative images 






Figure 2.3 Representative Ca2+ traces for young-adult and aged ex vivo osteocytes. Average 
Fluo-8 AM intensity normalized by average baseline intensity prior to load is plotted over time 
for all osteocytes in the field of view of a given A. 5-month-old mouse tibia (n=53 cells) and B. 
22-month-old mouse tibia (n=32 cells). Cyclic mechanical loading was initiated at t=25 s 
(arrows). Ca2+ peaks in each individual cell are defined as spikes in intensity that are greater than 





Figure 2.4 Load-induced Ca2+ signaling parameters in young-adult and aged osteocytes 
dyed with Fluo-8 AM. Based on Ca2+ peak identification from all Fluo-8 dyed osteocytes in the 
field of view (FOV) from 5-month-old (n=8 tibiae) and 22-month-old mice (n=6 tibiae). A. 
Percentage of responsive osteocytes (those that exhibit > 1 Ca2+ peak) of all cells in the FOV. B. 
Number of intracellular Ca2+ peaks exhibited by responsive osteocytes. C. Magnitude of Ca2+ 
peaks relative to baseline Fluo-8 AM intensity. D. Time between initiation of mechanical loading 




Figure 2.5 Load-induced Ca2+ signaling parameters in young-adult and aged osteocytes of 
Dmp1-Cre;Ai38flx/flx murine tibiae. A. Percentage of responsive of all cells in the FOV. B. 
Number of intracellular Ca2+ peaks exhibited by responsive osteocytes. C. Magnitude of Ca2+ 
peaks relative to baseline Fluo-8 AM intensity. D. Time between initiation of mechanical loading 





Figure 2.6 Ca2+ peak synchrony in osteocyte networks of young-adult and aged mice. 
Synchronous cell pairs, in which the time between the any of the Ca2+ peaks from each cell in the 
pair is less than 15 seconds, are totaled and normalized to the total number of cell pairs in the 
FOV. Data points represent normalized synchronous cell pair numbers according to cell-cell 
distance for each tibia sample (n=6-8/group). Trend line represents negative correlation between 





Chapter 3: Osteocyte Mechanosensing Following Short-Term and Long-Term Treatment 
with Sclerostin Antibody  
 
3.1 Introduction 
Osteoporosis is a systemic skeletal disorder characterized by low bone mass with 
deteriorated tissue microarchitecture, resulting in skeletal fragility and increased risk of fracture. 
More than 2 million osteoporotic fractures occurred in the United States in 201531. By 2025, 
fractures and costs associated are projected to reach over 3 million fractures incurring $25.3 
billion80. Compromised bone mass leading to osteoporotic fracture is the consequence of an 
unbalanced bone remodeling process, with higher osteoclastic bone resorption than osteoblastic 
bone formation81. Since osteocytes are considered as the primary skeletal mechanosensors 
responsible for directing bone formation and resorption processes, promising treatments for 
osteoporosis have been developed to target key bone regulatory proteins produced by osteocytes. 
One such therapy that has recently received approval by the U.S. Food and Drug Administration 
is a monoclonal antibody to sclerostin (Scl-Ab), trade name EVENITY™ (romosozumab-
aqqg)82. 
Encoded by the Sost gene, sclerostin is largely an osteocyte-specific protein83-85. 
Sclerostin binds LRP4/5/6 WNT co-receptors to inhibit WNT signaling86-88, a pathway which 
promotes bone formation and indirectly decreases bone resorption89, 90. A more detailed 
understanding of the effects of sclerostin on bone has been gleaned from the study of rare bone 
diseases such as sclerosteosis and van Buchem disease, both high bone mass disorders resulting 
from lack of sclerostin expression and, hence, increased bone formation91. Mutations of the Sost 
gene in sclerosteosis patients highlighted sclerostin as a potential target in osteoporosis92, 93, and 
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prompted preclinical studies using rodent models of genetic deletion or overexpression of Sost94, 
95. In Sost knock-out mice, a high bone mass phenotype is presented, characterized by increases 
in bone mineral density (BMD), bone volume, bone formation, and bone strength96. In contrast, 
transgenic mice overexpressing human Sost exhibit a low bone mass phenotype with reduced 
trabecular bone volume, cortical bone thickness, and decreased bone strength due to significantly 
reduced bone formation84. These studies motivated investigation into the use of antibodies 
targeting sclerostin to increase bone formation, mass, and strength in patients suffering from 
osteoporosis.  
In both pre-clinical models and patients treated with Scl-Ab, the initial response to 
treatment is robust. The first published report of pharmacological inhibition of sclerostin 
demonstrated complete recovery of estrogen deficiency‐induced bone loss in rats within three 
weeks of Scl-Ab treatment97. Additionally, treatment of BALB/c mice with Scl-Ab rapidly 
increases whole body BMD and is accompanied by a significant peak in circulating levels of the 
bone formation marker N-terminal propeptide of type 1 collage (P1NP) following initial 
treatment doses35. In post-menopausal women, significant percent increases in BMD in lumbar 
spine and total hip occurred as early as 2 months following biweekly treatment with 
romosozumab98. Furthermore, an increase in P1NP was noted one week after the initial dose of  
romosozumab was administered, and serum P1NP levels were greatest at one month33. 
While the initial rate of bone formation following Scl-Ab treatment is quite high, 
histological studies in animal models37 as well as clinical BMD measures have shown that this 
rate declines with long-term continuous treatment with Scl-Ab33. In multiple animal studies, the 
magnitude and rate of increase in P1NP is also attenuated upon repeat dosing with Scl-Ab35, 36, 99. 
Clinical trials demonstrate bone formation markers also eventually returning to baseline by six 
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months with monthly dosing of Scl-Ab, providing further translational confidence in preclinical 
results 33, 34. One possible explanation for this return to baseline bone formation response with 
long-term treatment with Scl-Ab is that osteocytes may be modifying their cellular responses to a 
new mechanical environment created by initial Scl-Ab treatment; namely increases in bone mass 
and, therefore, bone stiffness. However, this explanation is speculative without a method of 
assessing real-time osteocyte mechanosensitivity under Scl-Ab treatment. 
As previous work has shown, osteocytes exhibit robust mechanosensitive Ca2+ 
oscillations in response to mechanical stimuli such as fluid flow in vitro46-48, 68 or whole bone 
mechanical stimulation19, 73, 100. In an ex vivo murine tibia model, varying strains engendered on 
the anteromedial cortical bone surface yield differential osteocyte Ca2+ signaling 
characteristics19. This model is well-suited to characterize the mechanosensitivity of osteocyte 
networks in situ in mice under various pharmacological treatments or transgenic modifications 
and would allow us to assess whether changes to the mechanical environment (i.e. increases in 
bone mass with Scl-Ab treatment) result in changes in osteocyte intracellular Ca2+ 
mechanosignaling. Therefore, we hypothesize that osteocyte Ca2+ mechanosensitivity to whole-
bone mechanical loading is altered with long-term treatment of Scl-Ab, resulting in self-
regulation of the bone formation response as evidenced by diminished rate of increase of BMD 
and dampened serum P1NP response35. 
 
3.2 Materials and Methods 
3.2.1 Scl-Ab treatment  
Scl-Ab or phosphate buffered saline (PBS) vehicle was administered weekly via 
subcutaneous injections to 12-week-old female BALB/cJ mice (Stock #000651, The Jackson 
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Laboratory, Bar Harbor, ME, USA) at 25 mg/kg/week per the following groups: vehicle (8 
doses of PBS, n=16 mice), long-term treatment (8 doses of Scl-Ab, n=16 mice), or short-term 
treatment (6 doses of PBS followed by 2 doses of Scl-Ab at Day 42 & Day 49, n=16 mice) 
(Figure 3.1). Animals were housed 3-5 per cage and given access to food and water ad 
libitum (PicoLab 5053 and 5058, LabDiet, St. Louis, MO, USA). All animal procedures were 
approved by the Institutional Animal Care and Use Committee at Columbia University in 
accordance with Institute for Comparative Medicine and national guidelines. 
3.2.2 Micro-computed tomography scanning and analyses 
Cortical bone morphological parameters of the left tibia of each mouse were assessed 
biweekly via micro-computed tomography (micro-CT) using a Scanco VivaCT 80 system 
(Scanco Medical AG, Brüttisellen, Switzerland). Mice were anesthetized via isoflurane 
inhalation before and during scanning procedures. Scanning parameters were 55 kVp energy, 
109 µA intensity, and 300 ms integration time; reconstructed images had 5.0 µm isotropic voxel 
size. Prior to all analyses, a Gaussian filter was applied (sigma = 0.8, support = 1) to reduce 
noise. The cortical region of interest was set at 2.0 mm in length, centered midway between the 
tibial plateau and the distal tibiofibular junction. Global thresholds of 40% of the maximum gray 
scale value were used to classify cortical bone. Standard Scanco evaluation software was used in 
the calculation of cortical BMD and cortical thickness.  
3.2.3 Serum P1NP detection  
Whole blood was collected from the lateral caudal vein of the tail of each mouse using a 
needle prick at baseline (Day 0), immediately prior to administration of the last two doses of Scl-
Ab or PBS (Days 42 and 49), and four days following these time points, at which the peak P1NP 
levels are observed following dosage of Scl-Ab (Days 4, 46 and 53). Blood was left to clot at 
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room temperature for 20-30 minutes before being centrifuged at 10,000g for 5 minutes to 
separate the serum. Levels of serum P1NP at each time point were assessed by enzyme 
immunoassays in accordance with manufacturer protocols (ImmunoDiagnostic Systems, 
Fountain Hills, AZ, USA). 
3.2.4 Osteocyte intracellular Ca2+ imaging 
At Day 54, five days following the last treatment injection, mice were sacrificed by CO2 
inhalation and bilateral tibiae were immediately dissected under sterile conditions. Tibiae were 
maintained in supplemented cell culture media (αMEM + 5% calf serum, 5% defined fetal 
bovine serum) and incubated at 37°C, 5% CO2 for 2 hours. Tibia samples were then incubated 
with Fluo-8 AM (AAT Bioquest, Sunnyvale, CA, USA) dissolved in 20% Pluronic F-127 in 
DMSO (Invitrogen, Carlsbad, CA, USA) for 45 minutes, washed, and post-incubated for 
10 minutes before being transferred to a custom mechanical loading device for simultaneous 
loading and imaging.  
Using an Olympus FluoView FV1000 laser scanning confocal microscope with a 10x 
objective, Fluo-8 AM dyed osteocytes were visualized 20-30 µm below the anteromedial 
cortical bone surface of either the right or left tibiae, depending on Fluo-8 AM dye uptake. 
Fluo-8 AM was excited at 473 nm and fluorescence emissions were collected at 520 nm. 
Kalman filtering was applied during imaging with an acquisition time of 2.218 s/frame. 
Depending on the distribution of dye-loading and baseline cell signals, time-lapse images 
were recorded for n=5-8 tibiae/group/loading condition. 
3.2.5 Whole-bone mechanical loading 
Confocal time-lapse images were synchronized with a rest-inserted mechanical loading 
protocol to eliminate out-of-focus motion artifacts resulting from deformation of the bone 
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sample, with images being acquired every 5 seconds for 900 seconds total19. Five baseline 
images were acquired before mechanical loading was initiated via a trigger from the 
FluoView software to a 16-bit data acquisition (DAQ) card (NI USB-6210) and LabVIEW VI 
(National Instruments, Austin, TX, USA). Samples were maintained in supplemented cell culture 
media while cyclic mechanical loads were applied along the long axis of the whole bone using a 
custom-designed system19. A pre-load of 2 N was maintained, followed by cyclic axial loading 
of 1 Hz triangle waveforms with 4 s rest-insertion after each cycle to allow for confocal image 
acquisition. Two loading conditions were applied to samples from each treatment group: twenty-
four tibiae (8 per treatment group) were mechanically stimulated at a load magnitude of 10 N, 
while another 24 were stimulated at load magnitudes to match an anteromedial cortical bone 
strain of 2000 µƐ between treatment groups as determined by strain gauging experiments 
(3.2.7).  
3.2.6 Osteocyte image analysis 
Translation motion artifacts were removed using the StackReg image registration 
algorithm in ImageJ (U.S. National Institutes of Health; Bethesda, MD, USA). Cell bodies were 
manually traced using MetaMorph 7.0 (Molecular Devices, San Jose, CA, USA), and the average 
Fluo-8 AM intensity of the cell body was extracted for each cell as a function of time. Using 
MATLAB 2014b (The MathWorks, Natick, MA, USA), the average pixel intensity of each 
individual cell was normalized by the average of corresponding 5 baseline frames, and a Ca2+ 
peak was identified as a transient increase greater than 3 times the standard deviation of baseline 
intensity of each cell. The percentage of cells exhibiting ≥ 1 Ca2+ peak of all Fluo-8 dyed cells in 
the field of view, average number of Ca2+ peaks exhibited by responsive cells, average Ca2+ peak 
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magnitude relative to baseline intensity, and the average time to the first Ca2+ peak following 
initiation of mechanical loading were quantified for each tibia sample19, 46, 47. 
3.2.7 Local bone mineralization analysis 
Two days prior to sacrifice, a subset of mice (n=8/group) were injected subcutaneously 
with the fluorochrome alizarin red (30 mg/kg in 2% NaHCO3; Sigma-Aldrich, St. Louis, MO, 
USA) to capture bone mineralization at the Day 54 sacrifice time point. Following the Ca2+ 
imaging and loading period, alizarin red was imaged in the same field of view as the osteocyte 
network at 594 nm to create a 54 µm z-stack of images at a 0.25 µm resolution. Alizarin red 
intensity was summed over all images in the z-stack and the average intensity of bone tissue in 
the summed image stack was calculated for each sample using MATLAB 2014b. 
3.2.8 Anteromedial cortical bone strain measurement  
A subset of tibiae from Scl-Ab treated mice (n=4/treatment group) were frozen following 
Ca2+ imaging and used to experimentally quantify load-induced strain on the surface of the Ca2+ 
imaging region of interest. The tensile strain on the anteromedial cortical bone surface resulting 
from whole-bone compression was measured using commercial strain gauges (C2A-06-015LW-
120; Micro-Measurements - Vishay Measurements Group, Raleigh, NC, USA). Strain gauges 
were secured to the tibia anteromedial surface using cyanoacrylate adhesive (M-Bond 200 
Adhesive; Micro-Measurements - Vishay Measurements Group), consistent with the location of 
the typical osteocyte Ca2+ imaging region (Figure 3.2). Tibia samples were immersed in PBS 
while mechanical testing was performed using the custom ex vivo mechanical loading system. A 
500 mN pre-load was applied to secure the sample, after which the linear actuator was extended 
to 350 µm at 10 μm/s to compress the sample. The strain gauge output was connected to a 
conditioner and amplifier system (2100 System; Vishay Measurements Group), and strain values 
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during the loading period were recorded by the National Instruments DAQ board. Linear 
regression was performed to determine the average force-strain relationship for each of the Scl-
Ab treatment groups. Based on these relationships, corresponding load levels were calculated to 
match an anteromedial strain of 2000 µɛ across groups for subsequent mechanical loading and 
Ca2+ imaging. 
3.2.9 Statistics 
One-way ANOVA with Tukey’s HSD post hoc analysis was used to compare differences 
in means between treatment groups at each time point for cortical BMD, cortical thickness, and 
serum P1NP; differences between groups were similarly evaluated for endpoint measures of 
osteocyte Ca2+ signaling (responsive percentage, Ca2+ peak number, Ca2+ peak magnitude, time 
to 1st peak) as well as alizarin red mineralization. Differences in each Ca2+ signaling parameter 
between loading conditions (strain-matched vs. load-matched) were evaluated by Student’s t-test 
for each treatment group. Statistical significance is observed at p<0.05. 
 
3.3 Results 
3.3.1 P1NP response to Scl-Ab dosing is dampened with long-term treatment  
Serum levels of the bone formation marker P1NP were probed during Scl-Ab treatment 
in female BALB/cJ mice. The 58% decrease in mean P1NP levels in vehicle control mice over 
the course of the experiment likely reflects reduced bone formation as the mice approach skeletal 
maturity. Serum P1NP levels prior to the initiation of Scl-Ab treatment in all groups are 
comparable to those of vehicle control mice. Scl-Ab induced a peak in serum P1NP following 
the first Scl-Ab dose administered to the mice, evidenced by a 129% increase in P1NP at Day 4 
relative to D0 baseline in the long-term treated group, and a nearly 200% increase in P1NP at 
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Day 46 relative to Day 42 in the short-term treated group (Figure 3.3), both of which are 
significantly greater than age-matched vehicle controls (p<0.0001). In the long-term treated 
group, this robust peak in serum P1NP is absent following the 7th and 8th doses of the drug; 
however, P1NP levels remain significantly elevated (p<0.05) compared to vehicle control 
throughout the eight-week dosing period, except for prior to Day 49 dosing. Probing P1NP levels 
over two doses of Scl-Ab in the short-term group demonstrates that the elevated P1NP response 
to the first dose of Scl-Ab persists, even through timepoints immediately before and 4 days prior 
to the second dose.  
3.3.2 Cortical bone is enhanced with Scl-Ab treatment 
Cortical bone in BALB/cJ mice was significantly enhanced as early as 14 days following 
the initiation of Scl-Ab treatment compared to vehicle control (Figure 3.4). At Day 14, following 
two doses of Scl-Ab, mice from the long-term treated group demonstrated an increase in cortical 
tibia BMD of 5.6% and increase in cortical thickness of 11%, both compared to vehicle control, 
with comparable increases exhibited by mice from the short-term treated group between Day 42 
and Day 53. Cortical BMD remains significantly higher in long-term treated animals than vehicle 
control animals throughout the treatment period. However, the rate of change of percent 
increases over vehicle, while still demonstrating net increases in BMD, is attenuated after the 
initial two-week treatment (Table 3.1). 
3.3.3 Bone formation with Scl-Ab treatment results in differences in tibial force-strain 
relationships  
Using strain gauges affixed to the anteromedial cortical bone of Scl-Ab treated tibia, 
average force-strain relationships were determined for each of the three treatment groups (Figure 
3.5). These linear relationships were highly correlated with the average anteromedial surface 
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strain from a given force applied to tibia for each treatment group (R2>0.99). At the prescribed 
10 N load magnitude, it was determined that tensile strains of 2045 µƐ, 1843 µƐ, and 1560 µƐ 
were engendered on the anteromedial cortical bone of vehicle, short-term, and long-term treated 
samples during confocal imaging of osteocyte intracellular Ca2+, respectively (Table 3.2). To 
match an anteromedial cortical surface strain of 2000 µƐ across the treatment groups, load 
magnitudes of 9.8 N, 10.9 N, and 13.0 N were applied to samples from vehicle, short-term, and 
long-term treatment groups during osteocyte Ca2+ imaging, respectively. 
3.3.4 Osteocyte Ca2+ signaling in response to mechanical loading is diminished following short-
term Scl-Ab treatment, but persists after long-term treatment  
At Day 54 sacrifice, time-lapse images of osteocyte intracellular Ca2+ in at least five of 
the eight Fluo-8 dyed tibia per treatment group per loading conditions were processed for 
analysis (Table 3.3). Temporal dynamics of Fluo-8 intensity were analyzed for Ca2+ responses to 
mechanical loading for an average of 103 osteocytes per tibia sample. Osteocytes networks from 
each treatment group exhibited robust intracellular Ca2+ oscillations in response to cyclic axial 
compression.  In cells from samples matched to 10 N loading conditions, no significant 
differences were observed in percentage of responsive cells (Figure 3.6 A) nor the characteristics 
of the responsive osteocyte Ca2+ peaks (Figure 3.6 B-D) between either Scl-Ab treatment group 
and vehicle control. Under strain-matched loading conditions of 2000 µƐ, there was no 
difference in osteocyte Ca2+ signaling parameters between vehicle and long-term Scl-Ab treated 
groups. However, in the short-term treated group, the percentage of responsive cells was 
significantly reduced by about 16% compared to osteocytes in the strain-matched vehicle group 
(p<0.05, Figure 3.6 A). Initiation of Ca2+ signaling was also delayed as indicated by an increased 
time to the first Ca2+ peak observed during the imaging period (218.7 ± 36.4 s) compared to 
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vehicle control (149.1 ± 39.8 s) (Figure 3.6 D). Ca2+ peak magnitude and average number of 
Ca2+ peaks exhibited by the osteocytes did not differ between groups under strain-matched 
conditions. Overall, Ca2+ signaling measures did not differ between strain-matched and load-
matched conditions for each treatment group. 
3.3.5 Local bone mineralization is enhanced following short-term treatment of Scl-Ab 
By averaging the intensity of summed z-stack images of alizarin red in the region of 
osteocyte imaging, mineralization in response to short-term and long-term Scl-Ab treatment prior 
to animal sacrifice was estimated. Newly calcified bone was more evident in short-term treated 
tibia, with an alizarin red intensity that was 52% higher than vehicle and 19% higher than long-
term treated tibia in the region of interest (Figure 3.8). This increased intensity was only 
significant between vehicle and short-term tibia (p<0.01); alizarin red intensity of long-term 
treated tibia did not differ from short-term treated samples nor vehicle control. 
 
3.4 Discussion 
In both pre-clinical and clinical studies, Scl-Ab treatment has been shown to induce a 
robust initial phase of bone formation, evidenced by a rapid increase in BMD accompanied by a 
peak in circulating levels of P1NP. However, with continued long-term treatment with Scl-Ab, 
increases in BMD are slowed, driven by the reduction in bone resorption rather than increases in 
bone formation. Transient peaks in serum P1NP are also dampened in response to repeated 
doses. Thus, in their recent review of novel actions of sclerostin in bone, Holdsworth et al. posit 
that the bone formation response to Scl-Ab can be separated into two phases: an initial transient 
phase where Scl-Ab significantly and rapidly increases modeling-based bone formation; and a 
steady phase where BMD continues to increase due to long-term decreases in bone resorption, 
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but bone formation rates decline towards baseline levels with continuous treatment with Scl-
Ab94. Based on these observations, we hypothesized that rapidly enhanced bone mass with initial 
Scl-Ab treatment changes the mechanical environment that osteocyte networks experience under 
physiological loading conditions, therefore influencing their mechanosensing as measured by 
Ca2+ signaling responses (Figure 3.8 A). Given their role in mechanotransduction, this altered 
mechanosensing in osteocytes could possibly have downstream consequences affecting 
osteoblast bone formation processes, resulting in the dampened bone formation response to long-
term Scl-Ab treatment. 
 Serum levels of the bone formation marker P1NP were probed at different dosage points 
throughout the eight-week treatment period to investigate the bone formation response to Scl-Ab 
with short-term and long-term treatment. In agreement with a previous study of Scl-Ab treatment 
and P1NP dynamics in BALB/c mice35, the P1NP response after an initial dose of Scl-Ab was 
significantly larger than responses in both age-matched animals that had received multiple doses 
of the antibody as well as age-matched vehicle control animals. Our findings are also consistent 
with the pulsatile profile of serum P1NP levels following initiation of treatment with 
romosozumab in clinical trials33, 34. However, while we have confirmed the dampening of the 
pulsatile P1NP response following repeat dosing of Scl-Ab, serum P1NP levels in the long-term 
treated group remain significantly elevated compared to vehicle control throughout the treatment 
period. We attribute this to our use of an increased dosage of 25 mg/kg/week compared to the 
previous study in 8-10-week-old BALB/c mice, which used 10 mg/kg/week. Our study is the 
first to probe naïve serum P1NP responses immediately prior to and four days following 
consecutive treatment doses, and our use of a higher dosage of Scl-Ab may also explain the 
sustained peak of P1NP over two consecutive doses of the drug in the short-term treated animals.  
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Consistent with previous reports, our temporal in vivo micro-CT measures of murine tibia 
cortical bone show that Scl-Ab rapidly increased both cortical BMD and cortical thickness 
within the first two weeks of treatment. These increases are maintained in long-term treated tibia 
cortical bone throughout the eight-week period, although rates of increase slow with repeated 
dosing. Percent changes in cortical BMD and cortical thickness relative to vehicle control in 
long-term treated mice differ slightly from the previous study of a similar treatment timeline in 
BALB/c mice35, but may be explained by our local analysis of tibia cortical bone rather than 
whole body BMD.  Our analysis of bone mineralization in the region of osteocyte Ca2+ signaling 
also confirms that bone formation is still be occurring with long-term treatment, albeit not at the 
initial rapid rate as in mice that have been treated with short-term Scl-Ab dosing, confirming the 
effects of the steady phase where net positive bone balance is reflected by decreased resorption 
concurrent to extended bone formation. Taken together, our in vivo cortical bone formation data 
as well as our findings using alizarin red intensity as an ex vivo measure of mineralization 
support the two phases of response to Scl-Ab proposed by Holdsworth et al. 
It has been hypothesized that a rapid increase in bone mass during the initial, transient 
phase of response to Scl-Ab may lead to a reduction in local micro-strain on bone surface, thus 
activating negative feedback mechanisms to control bone formation94. Our strain-gauging data of 
Scl-Ab treated tibia confirms that increased cortical bone mass following long-term Scl-Ab 
treatment results in a decreased level of mechanical strain on the anteromedial cortical bone 
surface strain for a given mechanical load. For example, long-term Scl-Ab treatment contributes 
to a 23.7% decrease in anteromedial strain compared to age-matched vehicle controls (2045 με to 
1560 με) when both are loaded at 10 N. However, as we see with our Ca2+ signaling results in 
osteocytes of samples matched to a 10 N load between treatment groups, osteocyte 
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mechanosensing is maintained despite the differential strain engendered due to Scl-Ab treatment. 
Prior studies on bone formation with varying load/strain applications in vivo suggest that 
differential strain increments from 350-500 με are sufficient to induce significant differences in 
cortical bone formation responses101, 102. However, the BALB/c mice used in the current study 
may exhibit different responses to given strain increments than the low bone mass C57BL/6 in 
which these in vivo studies were conducted103. Nonetheless, we show that the altered whole-bone 
mechanics due to Scl-Ab treatment does not induce changes in osteocyte Ca2+ signaling.   
While the strain-matched osteocyte Ca2+ imaging experiments were expected to yield 
consistent mechanosensitive signaling characteristics between treatment groups due to the 
matched anteromedial cortical bone strain at our imaging region of interest, our analysis showed 
unexpected results. Fewer osteocytes responded with delayed Ca2+ peaks in short-term treated 
mice under strain-matched loading conditions. This reduced local responsiveness may reflect the 
behavior of “immature” osteocytes embedded in newly-formed cortical bone. Indeed, based on 
our alizarin red intensity data co-localized to regions of osteocyte Ca2+ signaling, we find that the 
osteocytes analyzed from the short-term group are located in bone that has been newly 
mineralized in response to initial Scl-Ab treatment. In mice, the bone formation rate has been 
shown to increase from about 1.5 to 2 µm3/µm2/day with 3 weekly doses of anti-sclerostin 
antibody104. Given our osteocyte Ca2+ imaging depth of ~20-30 µm below the bone surface, it is 
likely that we are capturing osteocytes in newly-formed bone under short-term (2 weekly doses) 
of Scl-Ab. Previous studies have shown that osteocyte networks are much more sensitive than 
osteoblasts to fluid flow stimulation in vitro46 and whole-bone compression ex vivo19 in terms of 
Ca2+ oscillations. Considering that an osteocyte is formed from an osteoblast that has been 
embedded in the matrix it has secreted, it is possible that newly mineralized osteocytes may not 
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yet exhibit the robust Ca2+ signaling capabilities seen in mature osteocyte networks. 
Additionally, while anteromedial cortical strains have been matched between treatment groups 
based on experimental strain gauge studies, the matrix-level material properties of the newly 
mineralized bone may influence the mechanosensing of newly-embedded osteocytes with short-
term Scl-Ab treatment. Ca2+ responses in the long-term treated group were consistent with 
osteocytes formed during normal bone homeostasis (vehicle), suggesting that cells embedded as 
a consequence of bone formation response to long-term Scl-Ab treatment eventually demonstrate 
a “mature” mechanosensing phenotype. Future studies focusing on osteocyte maturation under 
Scl-Ab treatment, such as morphological characteristics of in situ osteocytes between treatment 
groups, may support this theory. We do not observe differences in osteocyte Ca2+ signaling in 
load-matched tibia samples where different strains are engendered between treatment groups, 
which may be masking the localized effects of new bone formation on short-term treated 
osteocyte mechanosignaling. 
Taken together, we conclude that rapid increases in bone mass in the initial bone 
formation response to Scl-Ab treatment result in reduced Ca2+ signaling of newly-embedded 
osteocytes on the periosteal surface. (Figure 3.8 B). Future work will utilize in vivo micro-CT 
data to investigate periosteal bone modeling and remodeling dynamics in an effort to further 
attribute rapid mineralization of osteocytes under short-term treatment to the diminished 
mechanosensitivity of osteocyte Ca2+ signaling and identify the mechanisms responsible for the 
two phases of Scl-Ab bone formation response. This periosteal data will also more closely 
localize bone formation analysis to the osteocytes in the anteromedial cortical bone surface that 
we study in our ex vivo murine model of Ca2+ signaling. We also conclude that osteocyte 
mechanosensing is maintained with long-term Scl-Ab treatment. Mechanically induced Ca2+ 
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signaling in osteocytes has been shown to influence load-induced bone formation responses100, 
but there may be other factors downstream of Ca2+ signaling which contribute to the steady 
phase response to continuous Scl-Ab treatment. For instance, upregulation of various Wnt targets 
accompanies long-term treatment with Scl-Ab, which may exert a negative feedback to increased 
Wnt signaling and contribute to self-regulation of bone formation with long-term Scl-Ab 
treatment35, 105.  
 
3.5 Conclusions 
This study is the first to capture real-time, immediate, mechanosensitive Ca2+ responses 
to load in osteocytes from mice treated with Scl-Ab.  By comparing the peak characteristics of 
Ca2+ oscillations in osteocyte networks under load-matched tibial compression, we found that 
osteocyte mechanosensing is maintained and that the steady bone formation response to long-
term treatment may be attributed to self-regulation downstream of Ca2+ signaling. However, 
when mechanical strain is matched between treatment groups, osteocytes embedded during the 
initial transient bone formation response to Scl-Ab exhibit diminished Ca2+ signaling 
characteristics compared to mature osteocyte networks. These observations further our 







Table 3.1 Percent changes in cortical bone formation in response to short-term and long-
term Scl-Ab treatment. Biweekly in vivo micro-CT scans reveal increases in cortical BMD (mg 
HA/ccm) and cortical thickness (mm) within two weeks of initiation of Scl-Ab treatment for 
long-term (Day 14) and short-term (Day 53) treated animals. Percent changes (mean ± SD) are 
calculated relative to age-matched vehicle controls. Greyed values represent time points before 




Table 3.2 Loading parameters for tibia samples used for osteocyte Ca2+ imaging. Load-
matched samples in each treatment group were subjected to a 10 N load magnitude and resulting 
anteromedial cortical bone surface strains were calculated from force-strain relationships as 
determined by strain gauge experiments. To achieve a strain magnitude of 2000 µɛ, samples 
from each treatment group were subjected to mechanical load magnitudes calculated from 





Table 3.3 Experimental tibia samples and osteocytes for analysis. Ca2+ signaling in 
osteocytes from treated tibia samples were analyzed for both the load-matched and strain-
matched loading conditions, depending on the success of Fluo-8 intracellular Ca2+ dye-loading 







Figure 3.1 Timeline for Scl-Ab treatment. Female BALB/cJ mice were given weekly 
subcutaneous injections of 25 mg/kg Scl-Ab or PBS vehicle. Vehicle control mice were given 
eight doses of PBS. Short-term Scl-Ab treated mice received six doses of PBS before beginning 
Scl-Ab treatment at Day 42. Long-term Scl-Ab treated mice received eight doses of Scl-Ab. All 







Figure 3.2 Strain gauge experimental set-up. Strain gauges are affixed to the anteromedial 
cortical bone surface of frozen tibiae (left) and tested in the custom ex vivo axial mechanical 
loading system (right) while submerged in phosphate buffered saline. Cortical bone surface 






Figure 3.3 Serum P1NP levels during Scl-Ab treatment. P1NP was detected by enzyme 
immunoassay from serum samples taken immediately prior to and 4 days following treatment 
doses (Scl-Ab doses indicated by arrows; n=14-16 mice/group). Data are mean ± SD. *p<0.05, 




Figure 3.4 In vivo cortical bone responses to treatment with Scl-Ab. A. Cortical bone mineral 
density (BMD) and B. cortical thickness in a sub-set of Scl-Ab treated mice (n=4/group) as 
measured by biweekly in vivo micro-CT scans of the left tibia. Data are mean ± SD. *p<0.05, 
**p<0.01, ***p<0.001, ****p<0.0001 compared with vehicle control (one-way ANOVA, 





Figure 3.5 Experimentally-determined force-strain relationships in tibia from Scl-Ab 
treated mice. Linear regression determines linear relationships (dotted lines) between force 
applied and anteromedial cortical bone surface strain for vehicle, short-term, and long-term Scl-





Figure 3.6 Ca2+ signaling parameters of osteocytes from Scl-Ab treated mice. Ca2+ peak 
characteristics were determined for cells under load-matched (solid) and strain-matched 
(hatched) mechanical loading for each treatment group. A. Percentage of responsive cells (>1 
Ca2+ peak) was determined from of all cells in the field of view of each treated tibia sample. B. 
The average magnitude Ca2+ peaks relative to baseline intensities, C. the average number of Ca2+ 
peaks, and D. the time at which the first Ca2+ peak was observed were quantified based on 
individual osteocyte Fluo-8 intensities over the 900s loading period. n=5-8 tibia/group/loading 
condition. Data are mean ± SD. *p<0.05 compared with strain-matched vehicle control (one-way 




Figure 3.7 Local bone mineralization in Scl-Ab treated mice. Alizarin red intensity was 
averaged to estimate mineralization in the field of view of Ca2+ signaling in response to vehicle, 
short-term, and long-term Scl-Ab treatment (n=6-7 tibia/group). Data are mean ± SD. **p<0.01 







Figure 3.8 Bone formation processes in response to Scl-Ab treatment. A. In homeostasis, 
mechanical forces applied to whole bones result in tissue-level mechanical strain and subsequent 
fluid flow in the lacunar-canalicular system that is sensed by osteocytes. Osteocyte 
mechanosensing regulates bone formation processes, which in turn modify bone mass and whole 
bone mechanics. B. Under Scl-Ab treatment, osteoblastic bone formation is initially enhanced, 
resulting in a rapid, transient increase in bone mass. Local rapid bone mineralization diminishes 
Ca2+ signaling in newly-embedded osteocytes, either due to their immature phenotype or the 
mechanical properties of newly-mineralized bone. However, with long-term treatment, the P1NP 
response to Scl-Ab dosing indicative of osteoblast bone formation is dampened and increases in 
bone mass reach a steady phase. Osteocyte mechanosensing is maintained despite altered whole-
bone mechanical properties seen with long-term Scl-Ab treatment, suggesting that other 




Chapter 4: Real-Time Observation of Mechanosensitive Intracellular Calcium and Actin 
Network Dynamics in Ex Vivo Osteocytes 
 
This thesis chapter has been previously published, in part, in the manuscript:  
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D. Baik, Gehua Zhen, Xu Cao, Lynda F. Bonewald, Weiyang Jin, Lance C. Kam, X. 
Edward Guo. “Mechanically induced Ca2+ oscillations in osteocytes release extracellular 
vesicles and enhance bone formation”. Bone Research 2018 6(1):72-82. 
 
4.1 Introduction 
From a morphological standpoint, osteocytes lend their ability to sense whole-bone 
mechanical forces to their unique stellate features, longevity, and intercellular connectivity 
throughout a vast network embedded in the bone tissue106. Biochemical evidence of osteocyte 
mechanosensing is supported by studies investigating intracellular calcium (Ca2+) signaling in 
osteocytes in response to various mechanical stimuli50, 51, 77, 107. For example, when exposed to 
fluid shear in vitro and dynamic deformational loading of whole bones ex vivo, osteocytes 
exhibit robust, unattenuated oscillations in intracellular Ca2+, dependent on extracellular Ca2+ and 
the second messenger ATP19, 47. Furthermore, it has been shown that release of Ca2+ from 
intracellular stores temporally corresponds with and contributes to these robust oscillations in 
cytosolic Ca2+ oscillations48. Ca2+ oscillations in osteocytes are distinct from those of osteoblasts, 
more abundant than autonomous signals, and become more pronounced under increasing 
mechanical loading magnitudes19, 46, suggesting that osteocyte mechanosensitivity can be 
encoded through unique intracellular Ca2+ dynamics. 
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As osteoblasts embed in the bone matrix to differentiate into osteocytes, changes in 
cytoskeleton arrangement and distribution of structural elements occur, including formation of a 
dense cortical actin shell as well as actin-enriched structures that extend the entire length of the 
dendrites108-110. This uniquely-organized actin cytoskeleton of osteocytes can respond and 
restructure in response to mechanical loading70, 108. Previous work investigating dynamics of 
single osteocyte cytoskeletal components under flow showed that fluid shear introduces strains in 
the cortical actin network, demonstrating sensitivity of the actin cytoskeleton to mechanical 
stimuli111, 112. The influence of this early deformation of the osteocyte actin network on Ca2+ 
signaling was investigated in subsequent unpublished work from our group which utilized 
cytochalasin D to disrupt osteocyte actin polymerization prior to fluid flow, significantly 
reducing both the number and magnitude of flow-induced Ca2+ peaks113. While this suggests the 
importance of the actin cytoskeleton in initiating Ca2+ responses to fluid flow, there is little 
evidence of actin cytoskeleton dynamics occurring downstream, or dependent upon, Ca2+ 
signaling in osteocytes. 
Since Ca2+ signaling can regulate diverse cellular functions in multiple cell types, 
continued study of this mechanosensitive phenomenon in osteocytes begs the question of 
functionality. One consequence of Ca2+ signaling that is well-characterized in other cell types is 
Ca2+-dependent contractility. While classically attributed to muscle cells114, other cell types 
utilize this mechanism for specific functions, such as release of extracellular vesicles115 or wound 
healing116-118. Interestingly, the expression of muscle contraction-related proteins is upregulated 
as bone cells mature into osteocytes119. Regarding actin network responses downstream of Ca2+-
signaling, we have observed Ca2+-dependent, smooth muscle-mediated contractility in osteocytes 
in vitro with implications for cell-cell communication via extracellular vesicles100.  However, the 
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relationship between Ca2+ signals and downstream cytoskeletal dynamics in native osteocytes, as 
well as their mechanosensitive potential under physiological load, has yet to be explored. 
Our laboratory has developed a synchronized mechanical loading and imaging approach 
for investigating in situ osteocyte Ca2+ mechanotransduction19. This model maintains a viable 
osteocyte network in tibiae ex vivo, allowing for simultaneous application of physiological 
mechanical loads to the whole bone and imaging of osteocytes in situ. Intracellular dyes are 
utilized to access osteocytes in the bone tissue and fluorescently image real-time Ca2+ dynamics 
in response to load. The flexibility of this system permits the study of osteocyte 
mechanosensitivity in tibia samples from a variety of contexts, as we have seen in this body of 
work studying aged mice and mice receiving therapies promoting anabolic bone formation. 
Additionally, transgenic mice expressing fluorescent tags to various intracellular structures and 
molecules would permit visualization of a variety of real-time responses of in situ osteocytes to 
whole bone mechanical loading.  
In this study, our goal was to enhance our established model of ex vivo osteocyte 
mechanotransduction to include real-time, simultaneous, high-magnification visualization of 
Ca2+ signaling and actin network dynamics in response to mechanical loading to identify 
potential Ca2+-dependent contractile behavior as we have observed in vitro100. Based on our 
knowledge of mechanosensitive Ca2+ signaling in ex vivo osteocytes, we hypothesize that these 
load-induced Ca2+ oscillations will yield similarly mechanosensitive actin contractions in 




4.2 Materials and Methods 
4.2.1 Mice 
Lifeact mRFPruby mice, a gift from Michael Sixt and Roland Wedlich-Söldner at the 
Max Planck Institute of Biochemistry, were bred with C57BL/6 J mice (The Jackson 
Laboratory, Bar Harbor, ME, USA) to produce offspring with the filamentous actin (F-actin) 
network tagged with mRFP in all cell types, including osteocytes120, 121. These mice were 
genotyped for Lifeact by screening tail-snipped tissue samples for RFP. Ai38 mice were 
purchased from The Jackson Laboratory (B6;129S-Gt(ROSA)26Sortm38(CAG-GCaMP3)Hze/J mice) and 
bred to Dmp1-Cre mice (a gift from Dr. Lynda Bonewald). Dmp1-Cre;Ai38flx/flx  mice expressing 
the Ca2+ indicator GCaMP3 targeted to osteocytes71-73 were then bred to Lifeact mRFP+/- mice to 
produce triple transgenic Dmp1-Cre;Ai38flx/flx;Lifeact mRFP+/- mice (Figure 1). Mice were 
genotyped for Cre and Ai38 using qPCR on tissue lysates with previously noted primer 
sequences71, 72. All animals were housed 2-5 per cage and given access to food and water ad 
libitum (PicoLab 5053 and 5058, LabDiet, St. Louis, MO, USA). All animal procedures were 
approved by the Institutional Animal Care and Use Committee at Columbia University in 
accordance with Institute for Comparative Medicine and national guidelines. 
4.2.2 Osteocyte intracellular Ca2+ and actin imaging 
Three-month-old Lifeact mRFP+/- mice were sacrificed by CO2 inhalation and bilateral 
tibiae were immediately dissected under sterile conditions. Tibiae were maintained in 
supplemented cell culture media (αMEM + 5% calf serum, 5% defined fetal bovine serum) and 
incubated at 37°C, 5% CO2 for 2 hours. Tibia samples were then incubated with Ca
2+ indicator 
Fluo-8 AM (AAT Bioquest, Sunnyvale, CA, USA) dissolved in 20% Pluronic F-127 in DMSO 
(Invitrogen, Carlsbad, CA, USA) for 45 minutes, washed, and post-incubated for 10 minutes 
61 
 
before being transferred to a custom mechanical loading device for simultaneous loading and 
imaging. Tibiae from three-month-old Dmp1-Cre;Ai38flx/flx;Lifeact+/-  mice were similarly 
dissected and maintained in supplemented media before being immediately placed in the custom 
mechanical loading device. 
Using an Olympus FluoView FV1000 laser scanning confocal microscope with a 60x 
long working distance objective, Fluo-8 AM dyed osteocytes expressing Lifeact mRFP (Fluo-
8 + Lifeact) or osteocytes expressing both GCaMP3 and Lifeact mRFP (GCaMP3 + Lifeact) 
were visualized 20-30 µm below the anteromedial cortical bone surface of either the right or 
left tibiae, depending on Fluo-8 AM dye baseline signals. Fluo-8 AM and GCaMP3 Ca2+ 
indicators were excited at 473 nm and fluorescence emissions were collected at 520 nm, while 
Lifeact mRFP was sequentially excited at 559 nm and collected at 618 nm. Kalman filtering 
was applied during sequential imaging with an acquisition time of 2.218 s/frame acquired 
every 6 seconds.  
4.2.3 Biochemical stimuli of intracellular Ca2+ 
 For Fluo-8 + Lifeact osteocytes, either 20 mM ATP (20 mM, n=15 cells) or ionomycin 
(20 µM n=33 cells) (both Sigma-Aldrich, St. Louis, MO, USA) was added via micro-pipette 
to tibia samples secured in the custom loading device while Ca2+ and actin network dynamics 
were imaged simultaneously. For GCAMP3 + Lifeact osteocytes, either ATP (10 mM, n= 6 
cells) or ionomycin (10 µM, n= 6 cells) was added to the media well of the loading system via 
syringe. Identical volumes of culture media were similarly introduced to the media well 
before each biochemical stimulus as a negative control.  
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4.2.4 Whole-bone mechanical loading 
For mechanical loading experiments, confocal time-lapse images were synchronized 
with a rest-inserted mechanical loading protocol to eliminate out-of-focus motion artifacts 
resulting from deformation of the bone sample. Five baseline images were acquired before 
mechanical loading was initiated via a trigger from the FluoView software to a 16-bit data 
acquisition (DAQ) card (NI USB-6210) and LabView VI (National Instruments, Austin, TX, 
USA). Samples were maintained in supplemented cell culture media while cyclic mechanical 
loads were applied along the long axis of the tibia using a custom-designed system19. A pre-load 
of 2 N was applied, followed by cyclic axial loading of 1 Hz triangle waveforms with 5 s rest-
insertion after each cycle to allow for confocal image acquisition. A load magnitude of 8 N was 
applied to Fluo-8 + Lifeact tibia samples (n=19 cells). For GCAMP3 + Lifeact samples, loading 
bouts with magnitudes of 4 N and 8 N applied to each tibia in random order with 15 minutes of 
rest between bouts. These samples were categorized as undergoing either an increasing load 
sequence (4 N → rest → 8 N; n=6 cells) or decreasing load sequence (8 N → rest → 4 N; n=6 
cells). 
4.2.5 Osteocyte image analysis 
Analysis of Fluo-8, Lifeact mRFP, and GCaMP3 images was performed in MATLAB 
2014b (The MathWorks, Natick, MA, USA). Strain fields in individual cells were directly 
estimated from time-lapse Lifeact mRFP images without the need to first estimate 
displacements, resulting in a very simple method and low computational cost122. From these 
strain fields, average strains of the intracellular cytoskeletal network relative to the long and 
short axes of the osteocyte cell body were calculated over time. Average pixel intensity of the 
Ca2+ indicator in each individual cell was normalized by the average intensity of 
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corresponding baseline frames. A Ca2+ peak was defined as a transient increase greater than 
three times the standard deviation of the baseline intensity noise in each cell. A contraction in 
either the long or short axis of the cell was defined by a decrease and recovery of normal 
strain with a minimum prominence of 1.5% strain. For Fluo-8 + Lifeact cells, the frequency of 
Ca2+ peaks and contractions in both the long and short axes of the cells were calculated for  
cells with >2 Ca2+ peaks (n=9 cells). A measure of percent synchrony between the 
contractions in each of the cell axes and Ca2+ peaks was calculated as described previously48. 
For GCaMP3 + Lifeact cells, the number of Ca2+ peaks and total contractile events, contractile 
events along the short axis of the cell, and contractile events along the long axis of the cell 
were quantified. 
4.2.6 Statistics 
All data are presented as mean ± standard deviation. Paired Student’s t-test was used to 
determine significant differences in frequency between Ca2+ peaks and contractile events in 
Fluo-8 + Lifeact cells. For GCaMP3 + Lifeact cells, the number of Ca2+ peaks, total contractile 
events, contractile events along the short axis of the cell, and contractile events along the long 
axis of the cell were compared between load levels using paired Student’s t-test; comparisons 
were made between the first loads of different loading sequences (increasing vs. decreasing) 
using Student’s t-test. Statistical significance is observed when p<0.05. 
 
4.3 Results 
4.3.1 Visualizing intracellular Ca2+ and actin cytoskeleton in ex vivo osteocytes 
 Intracellular Ca2+ and actin network dynamics were successfully measured using confocal 
microscopy in both Fluo-8 + Lifeact osteocytes and GCaMP3 + Lifeact osteocytes (Figure 4.2). 
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Using 60x magnification, fields of view with as many as six individual osteocytes could be 
imaged. Sequential excitation of the two channels allowed for collection of time-lapse images 
without spectrum excitation/emission interference, and the dwell time between load cycles was 
sufficient to obtain both images after a given load cycle as well as capture the oscillatory 
characteristics of intracellular Ca2+ dynamics.  
4.3.2 Osteocyte Ca2+ and contractile dynamics in response to biochemical stimuli 
Both ATP and ionomycin elevated Ca2+ levels in the ex vivo Fluo-8+Lifeact and 
GCaMP3 + Lifeact osteocytes by at least two-fold (Figures 4.3 - 4.5). A decrease in actin 
network strain along the normal axes of the osteocytes was observed immediately following the 
increase in Ca2+ in response to each biochemical stimulus. For ATP-stimulated cells, these 
contractile dynamics were transient with Ca2+ elevation while in ionomycin-treated cells, 
contraction persisted throughout the elevation of intracellular Ca2+. ATP and ionomycin induced 
a Ca2+ response in 73.3% and 90.9% of Fluo-8 + Lifeact cells, and a contraction was present in 
54.5% and 50.0% of these cells that showed a Ca2+ response to ATP and ionomycin, respectively 
(Figure 4.3). ATP induced a transient increase of intracellular Ca2+ in 67% of GCaMP3 + Lifeact 
osteocytes, followed by contractions in 20% of responsive cells (Figure 4.4). Introduction of 
ionomycin resulted in step-elevation of Ca2+ in 83% of the GCaMP3 + Lifeact cells observed, of 
which 80% exhibited contractile behavior (Figure 4.5). Addition of media volume to the system 
via syringe had no quantifiable effect on GCaMP3 + Lifeact actin dynamics.  
4.3.3 Osteocytes exhibit Ca2+-dependent mechanosensitive contractions dependent upon 
sequence of mechanical load magnitude  
Fluo-8 + Lifeact osteocytes demonstrated robust and repetitive Ca2+ spikes under cyclic 
mechanical loading (Figure 4.6A). Of cells that responded with mechanically-induced Ca2+ 
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peaks, 41.2% also exhibited a decrease and recovery in strain along at least one of the normal 
axes of the cell. On average, the magnitude of incremental contractile strain following a Ca2+ 
peak was 1.8%. Quantification of osteocyte Ca2+ oscillations and contractions over time reveals 
an average Ca2+ peak frequency of 0.012 ± 0.004 Hz and average contraction frequency of 
0.0093 ± 0.003 Hz, which were not found to be significantly different in cells exhibiting both 
Ca2+ peaks and contractile events. Connecting individual Ca2+ peaks with subsequent 
contractions revealed the majority of Ca2+ peaks (>50%) were synchronous with a cytoskeletal 
contraction. 
Osteocytes from Dmp1-Cre;Ai38flx/flx;Lifeact mRFP+/-  tibiae loaded at both 4 N and 8 N 
showed significantly amplified Ca2+ signaling at the higher load level as expected, regardless of 
load sequence (Figure 4.7)19. The average number of actin contractions along either axis of the 
cell were enhanced from an average of 2.3 ± 2.1 to 4.2 ± 3.1 contractions with increasing load 
sequence (p<0.05) (Figure 4.8). However, there were no significant differences in the number of 
contractile events between load levels with decreasing load sequence. Contractile events were 
dominated by those along the short axis of cells in both load levels of the decreasing load 
sequence, but not in the increasing load sequence. When comparing only the first load level from 
each sequence, representing an unpaired comparison of 4 N and 8 N events, there is only a 
significant difference in number of Ca2+ peaks between the two load levels while the number of 
contractile events remained consistent. 
 
4.4 Discussion 
Osteocytes are a cell type in which mechanosensitive potential as well as downstream 
mechanosignaling processes are dependent upon their unique actin cytoskeleton morphology and 
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connectivity in the bone matrix. Additionally, the mechanical stimuli experienced by these cells 
is dependent upon fluid flow in the lacunar-canalicular system (LCS) resulting from tissue-level 
compressive and tensile strains in the bone. Therefore, it is ideal to preserve the osteocyte 
network in situ and apply physiological loads to whole bone ex vivo when elucidating 
mechanotransduction mechanisms. We have successfully captured and quantified both Ca2+ and 
actin dynamics of ex vivo osteocytes and identified Ca2+-dependent contractile behavior under 
various stimuli. Ca2+ signaling and contractile behavior in response to mechanical loading was 
first identified in tibial osteocytes of Lifeact mRFP+/- mice incubated with the intracellular Ca2+ 
indicator Fluo-8AM. This Ca2+ indicator has been used in previous studies of ex vivo osteocyte 
mechanosensitivity by our group and others for the robust visualization of Ca2+ dynamics of cells 
embedded in the dense bone tissue19, 51, 107, 123. When incubated with tibiae dissected from Lifeact 
mRFP+/- mice, in which F-actin tagged with mRFP via the Lifeact probe, simultaneous 
visualization of Ca2+ and actin network dynamics of individual osteocytes was possible. The 
frequency of Ca2+ signaling and contractions in response to mechanical loading as well as the 
synchrony of the two intracellular events were quantified for the first time using this 
experimental method. 
Studies measuring intracellular dynamics at a high magnification and long imaging 
periods rely on stable intracellular fluorescent molecules while maintaining physiological 
integrity of the intracellular processes in situ. This study also builds upon the previously 
established protocol by developing and utilizing a novel mouse model with targeted expression 
of fluorescent proteins to observe intracellular Ca2+ and actin dynamics of live osteocytes within 
the bone tissue immediately after tissue explant. Dmp1-Cre;Ai38flx/flx;Lifeact mRFP+/- mice were 
developed with the genetically encoded Ca2+ indicator GCaMP3 targeted to osteocytes which 
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also express Lifeact mRFP. Samples from these mice could be dissected and imaged 
immediately, eliminating the need for incubation periods with intracellular dyes to reach 
osteocytes deep within the bone tissue, thus minimizing time between explant and imaging. 
Indeed, the Ca2+ and contractile dynamics observed in GCaMP3 + Lifeact osteocytes in response 
to ATP, ionomycin, and mechanical loading are similar to those observed in Lifeact mRFP+/- 
osteocytes dyed with Fluo-8 AM. These triple transgenic samples could therefore be used for 
longer imaging sessions, allowing us to pair mechanical loading data and thus investigate 
mechanosensitivity of the intracellular dynamics in individual osteocytes.  
This work is the first to demonstrate the a Ca2+-dependent contractile mechanism in 
osteocytes in situ, with both Ca2+ peaks and actin network contractions being enhanced with load 
magnitude. Decreases in normal strains along the short and long axes of the cell were consistent 
with the contractile behavior we have previously observed in osteocytes in vitro. To confirm the 
dependence of actin contractions on Ca2+ dynamics rather than experimental artifact, ATP and 
ionomycin were used to chemically stimulate a Ca2+ response with different temporal profiles in 
the absence of mechanical load. Indeed, the normal strain profiles along the long and short axes 
of the osteocytes mimicked the Ca2+ dynamics for each stimulus. For example, ATP stimulated 
cells displayed a recovery to baseline in both Ca2+ and actin strain, demonstrating a reversible, 
phasic contraction. These phasic contractions were also coincident with Ca2+ peaks induced by 
mechanical loading. The frequencies of the load-induced Ca2+ transients and contractions were 
not found to be significantly different and the majority of these intracellular events were 
synchronous with one another in individual cells, suggesting their coordination in response to 
mechanical load.  
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The characteristics of the Ca2+-dependent actin network contractions we identify in 
osteocytes in situ are similar to those observed in vitro. We have previously characterized 
contractile dynamics of single MLO-Y4 cells under both biochemical stimuli and fluid flow and 
showed a decrease and recovery of the average intracellular actin normal strain in the height of 
the cell to a magnitude of 0.015-0.02 strain100. Contractile events detected in Fluo-8 + Lifeact 
and GCaMP3 + Lifeact cells were of comparable magnitude and time scale. However, one 
benefit of our ex vivo experimental setup is the ability to observe multiple phasic contractions 
with prolonged mechanical loading cycles, whereas contractile dynamics were only recorded for 
200 seconds at most in single cells in vitro. While other studies have identified multiple, phasic, 
tissue-level contractions corresponding to intracellular Ca2+ transients124, 125, we are for the first 
time demonstrating Ca2+-dependent contractile behavior in osteocytes at the cellular level. 
This Ca2+-dependent contractile mechanism in osteocytes could potentially contribute to 
other downstream mechanosensitive pathways, such as release of extracellular vesicles (EVs)100.  
Vesicle release has recently been highlighted as an important means of intercellular 
communication, whereby cells package proteins and genetic materials in EVs to shuttle their 
contents amongst one another126. EV release is stimulated by actomyosin contractility in 
endothelial cells127 and facilitated by Ca2+/actin dynamics in mast cells115. Considering actin 
networks have been implicated in mechanically-induced protein responses in osteocytes128, it is 
feasible that osteocyte contractility may facilitate release of EVs containing key bone regulatory 
proteins in situ. Indeed, a recent morphological study showed strong co-localization of RANKL 
to vesicle-like structures in osteocytes and OPG-positive structures in the canaliculi, indicating 
intracellular transport of the proteins in the canaliculi129. This is further confirmed by 
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multiplexed confocal imaging of in situ osteocytes revealing vesicle-like structures present 
throughout the bone matrix surrounding the osteocytes and in-between dendrites69.  
Our paired data of intracellular dynamics at two mechanical load magnitudes indicate that 
the mechanosensitivity of the osteocyte contractions is dependent upon loading history. 
Increasing load sequences highlight the differential contractile responses between load levels in 
individual cells while decreasing load sequences appear to saturate the contractile mechanism, as 
contractions are not significantly different from the 8 N load to the 4 N load. These differential 
responses have previously been observed in other bone cell types. For example, primary 
osteoblasts have been shown to exhibit different anabolic gene expression and protein production 
responses to increasing/decreasing fluid shear stress in vitro130.  Consideration of additional load 
levels and configurations would provide further insight into dependence of the responses on 
loading history. Differences in contractions between cell axes also suggest dependence of the 
mechanism on osteocyte morphology, which warrants further exploration. 
Future work will determine relative contributions of mechanical loading and Ca2+ 
dynamics on actin contractions using actin stabilizing compounds and inhibitors of Ca2+ 
signaling. Previous studies have utilized several inhibitors of Ca2+ signaling in determining 
relevant pathways contributing to oscillatory responses to load, suggesting that antagonists for 
the ATP pathway and the endoplasmic reticulum would be most efficient in inhibiting Ca2+ 
responses in osteocytes and studying the effect on actin network contractions19, 47. Furthermore, 
jasplakinolide has been used in vitro to stabilize actin filaments by accelerating actin polymerization, 
thereby inhibiting depolymerization131-133. Unpublished work from our group has demonstrated 
inhibition of contractile dynamics without impairing Ca2+ responses in MLO-Y4 cells in vitro using 
jasplakinolide113. Thus, jasplakinolide would be useful for future studies aiming to delineate the roles 




Biochemical and fluid flow-induced Ca2+ responses have been shown to induce 
contractions of the actin cytoskeleton in osteocytes in vitro. Here, we confirm this functional 
consequence of Ca2+ signaling in osteocytes in their native 3D network by expanding upon our 
ex vivo model of osteocyte mechanosignaling to simultaneously visualize intracellular Ca2+ and 
the actin cytoskeleton in single cells in response to whole-bone loading using transgenic mice. 
We have identified contractile events corresponding to load-induced Ca2+ peaks in situ while 
demonstrating a potential sensitivity to mechanical loading history. This Ca2+-dependent 
contractility is a potential target for therapies for conditions in which osteocyte 








Table 4.1 Tibia samples and osteocytes analyzed for intracellular responses. In Lifeact 
mRFP mice tibiae dyed with Fluo-8 AM (Fluo-8 + Lifeact), intracellular responses were 
analyzed in cells under biochemical stimulation by ATP and ionomycin, as well as 
mechanical loading at an 8 N load magnitude. Osteocytes from Dmp1-Cre;Ai38flx/flx;Lifeact 
mRFP+/- mice (GCaMP3 + Lifeact) were analyzed in response to biochemical stimulation as 








Figure 4.1 Gene targeting strategy used to generate Dmp1-Cre;Ai38flx/flx;Lifeact mRFP+/- 
mice. The Ai38 floxed GCaMP3 reporter mouse line is Cre-dependent via a lox-stop-
lox cassette. Osteocyte-specific GCaMP3 expression is achieved by crossing the Ai38 reporter 
mice with Dmp1-Cre mice in which Cre recombinase is driven by the osteocyte-specific protein 
Dmp1. Dmp1-Cre;Ai38flx/flx mice are bred to Ai38flx/flx;Lifeact mRFP+/- mice, in which F-actin is 
tagged to RFP via the Lifeact probe, resulting in mice with osteocytes expressing both GCaMP3 






Figure 4.2 Visualization of intracellular Ca2+ and actin cytoskeleton in ex vivo osteocytes. A. 
Confocal microscopy is used with a custom mechanical loading system to capture osteocyte 
intracellular responses to whole-bone mechanical loading. Intracellular Ca2+ dynamics are 
visualized using either B. incubation of tibia samples with the intracellular Ca2+ dye Fluo-8 AM, 
or C. osteocyte-specific expression of GCaMP3. Both experimental methods capture osteocyte 





Figure 4.3 Biochemically-induced Ca2+ responses and subsequent actin dynamics in Fluo-8 
+ Lifeact osteocytes. Representative time courses of intracellular Ca2+ and actin network strain 
along the short (ɛ, short) and long (ɛ, long) axes of osteocytes stimulated by addition of either A. 
20 mM ATP (n=15 cells), or B. 20 µM ionomycin (n=33 cells) to the experimental system, 
indicated by arrows. A contractile event is identified following the peak in intracellular Ca2+ in 
response to ATP (+) while the contraction in response to ionomycin-induced Ca2+ influx begins 






Figure 4.4 ATP-induced Ca2+ responses and subsequent actin dynamics in GCaMP3 + 
Lifeact osteocytes. Representative time courses of intracellular Ca2+ and actin network strain 
along the short (ɛ, short) and long (ɛ, long) axes of an osteocyte stimulated by the addition 10 
mM ATP (n= 6 cells). Addition of media control and biochemical stimulus are indicated by 
arrows. Time-lapse images of GCaMP3 and Lifeact mRFP for the given osteocyte are displayed 
at time points before (t=0 s) and immediately after addition of ATP (t=336 s), and at return to 






Figure 4.5 Ionomycin-induced Ca2+ responses and subsequent actin dynamics in GCaMP3 
+ Lifeact osteocytes. Representative time courses of intracellular Ca2+ and actin network strain 
along the short (ɛ, short) and long (ɛ, long) axes of an osteocyte stimulated by the addition 10 
µM ionomycin (n= 6 cells). Addition of media control and biochemical stimulus are indicated by 
arrows. Time-lapse images of GCaMP3 and Lifeact mRFP for the given osteocyte are displayed 
at time points before (t=0 s) and after addition of ionomycin (t=500 s), and at a point of sustained 
elevated Ca2+ (t=800s). Contractile dynamics in both axes of the cell initiate following the 






Figure 4.6 Mechanically-induced Ca2+ responses and subsequent actin dynamics in Fluo-8 
+ Lifeact osteocytes. A. Representative time courses of intracellular Ca2+ and actin network 
strain along the short (ɛ, short) and long (ɛ, long) axes of an osteocyte under 8 N of cyclic 
mechanical loading applied to the whole tibia. Contractile events (+) are identified following 
peaks in intracellular Ca2+ (*). Loading initiation indicated by arrow. B. The frequencies of Ca2+ 
peaks and actin contractile events are quantified and compared for cells exhibiting both Ca2+ 







Figure 4.7 Mechanosensitive Ca2+ responses and actin contractions in GCaMP3 + Lifeact 
osteocytes. Representative time courses of intracellular Ca2+ and actin network strain along the 
short (ɛ, short) and long (ɛ, long) axes of an osteocyte under both A.  4 N of cyclic mechanical 
loading, or B. 8 N of cyclic mechanical loading applied to the whole tibia. These intracellular 
dynamics are considered responses to an increasing load sequence for this cell. Contractile 





Figure 4.8 Ex vivo osteocyte intracellular Ca2+ and contractile events under different 
loading sequences. Paired data are shown for osteocytes experiencing increasing (n=6 cells) and 
decreasing (n=6 cells) load sequences, with the average events between load levels shown as a 
bolded line. The number of intracellular Ca2+ peaks (A, B) and total intracellular contractions (C, 
D) are evaluated for each load level in each loading sequence. Contractions are further 
characterized in increasing and decreasing load sequences by those occurring along the short (E, 
F) and long axes (G, H) of individual osteocytes. *p<0.05, between load levels within a load 
sequence (paired Student’s t-test). #p<0.05, ##p<0.01, short axis vs. long axis contractions within 
a load level (paired Student’s t-test). $p<0.05, between first load levels applied (Student’s t-test).   
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Chapter 5: Conclusion 
 
5.1 Summary 
 Surmounting evidence over the past few decades has solidified the osteocyte as the 
primary mechanosensor in bone. This cell type is primed for this role by its longevity, 
distribution as an interconnected network throughout the bone tissue, stellate morphology, and 
mechanosensitive production of key bone regulatory proteins. In fact, the development of 
osteoporosis is thought to stem from an imbalance of osteocyte-mediated bone resorption by 
osteoclasts and bone formation by osteoblasts, which implies a disruption of normal 
mechanotransduction processes. A particularly robust mechanosensitive phenomenon in 
osteocytes that is observable in real time in systems of multiple scales is intracellular calcium 
(Ca2+) signaling.  Osteocyte cell networks both in vitro and ex vivo exhibit robust oscillations in 
intracellular Ca2+ under mechanical stimulation and are more responsive than osteoblasts, further 
supporting their role as the major mechanosensing cell type in bone. Thus, the real-time 
mechanosensitive potential of osteocytes can potentially be characterized in a variety of contexts 
using an ex vivo murine tibia model of osteocyte Ca2+ responses to whole-bone loading. This 
body of work explores ex vivo osteocyte Ca2+ signaling in a model of aging as well as in mice 
undergoing a recently-approved treatment for osteoporosis. 
The first chapter of this thesis explored the possibility of diminished osteocyte 
mechanosensing with age, supported by evidence of a blunted anabolic response to mechanical 
loading in vivo in aged mice. Tibiae were dissected from 5-month-old (young-adult) and 22-
month-old (aged) mice and incubated with Fluo-8 AM to image real-time osteocyte Ca2+ 
dynamics in response to whole-bone mechanical loading using confocal microscopy. Tibia from 
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aged mice demonstrated a significantly thinner cortex than young-adult mice, confirming age-
induced bone loss. When loading was applied to match 1500 µƐ strain at the anteromedial 
cortical bone surface, osteocytes in this region responded with oscillatory Ca2+ peaks; however, 
fewer cells demonstrated Ca2+ responses in aged mice and the initiation of these responses was 
significantly delayed. Additionally, synchrony analysis revealed an inverse linear relationship 
between responsive cell pairs and cell-cell distance in 5-month-old mice that was absent in 22-
month-old mice. This suggests a diminished mechanosensitivity in aged osteocytes and lack of 
ability to generate coordinated Ca2+ responses to mechanical load that are seen in young-adult 
mice, possibly due to the reduction in osteocyte cell density and dendricity seen in aged female 
mice or a blunted mechanosensitive ATP pathway response upstream of Ca2+ signaling. This 
evidence regarding the real-time mechanosensitive potential of aged osteocytes compared to 
young-adult osteocytes provides insight into the impairment of long-term bone formation 
processes with aging. 
Chapter 3 of this work investigated the effects of a newly-approved treatment for 
osteoporosis, commonly influenced by age-induced bone loss, on osteocyte mechanosensing. 
The rapid increase in bone mass resulting from initial treatment with sclerostin antibody (Scl-
Ab) may alter both the whole-bone and local mechanical environments of osteocytes in the bone 
matrix, resulting in altered mechanosensitivity and possibly contributing to the bone formation 
response return to steady state with long-term treatment. To investigate this, mice were treated 
with either vehicle, short-term, or long-term Scl-Ab for eight weeks. Mice were sacrificed, and 
tibiae were dissected for simultaneous ex vivo mechanical loading and osteocyte Ca2+ imaging. 
The bone formation marker P1NP was probed at different time points throughout the treatment 
period to confirm the blunting of serum P1NP response to Scl-Ab doses with long-term 
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treatment. Micro-CT analyses of cortical bone revealed a rapid initial increase of BMD and 
cortical thickness with Scl-Ab treatment, with decreasing rates of bone accrual under long-term 
treatment as expected. Indeed, increased BMD following Scl-Ab treatment resulted in 
differences in force-strain relationships in the anteromedial cortical bone as measured by ex vivo 
tibial strain gauging. When cyclic mechanical loading was applied to tibia from all treatment 
groups at a 10 N magnitude, there were no significant differences in osteocyte Ca2+ response 
parameters, suggesting maintained mechanosensitivity despite accrual of bone mass and 
resulting differences in strain magnitudes. However, when loading was applied to match 2000 µƐ 
at the anteromedial cortical bone surface in all samples, osteocytes from short-term treated mice 
exhibited fewer responsive osteocytes with delayed Ca2+ signaling. Alizarin red intensity 
analysis in the field of view of osteocyte imaging revealed that newly calcified bone was more 
evident in short-term treated bones than in long-term or vehicle groups. This suggests that 
osteocytes from the short-term treatment group are embedded in newly-formed cortical bone, 
which may present altered local mechanical properties of newly-mineralized bone or a less-
mature osteocyte phenotype compared to vehicle or long-term treated osteocytes. These 
observations further our understanding of the mechanisms of different phases of bone formation 
responses to Scl-Ab treatment. 
Chapter 4 seeks to identify a functional consequence of the mechanically-induced Ca2+ 
responses that have been characterized in Chapters 2 and 3 of this work, as well as by others, and 
its mechanosensitive potential. Most recently, our lab has demonstrated that mechanical 
stimulation of osteocytes activates Ca2+-dependent contractions and enhances the production and 
release of extracellular vesicles containing bone regulatory proteins in vitro. We hypothesized 
that load-induced Ca2+ oscillations yield similarly mechanosensitive actin contractions in 
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osteocytes residing in their native 3D network, and therefore enhanced our established system for 
ex vivo loading of whole bone and simultaneous imaging of Ca2+ to include visualization of the 
actin cytoskeleton network in live cortical osteocytes. Ex vivo tibiae from Lifeact mice dyed with 
Fluo-8 AM (Fluo-8 + Lifeact) as well as triple transgenic Dmp1-Cre;Ai38flx/flx;Lifeact mRFP+/- 
(GCaMP3 + Lifeact) were utilized to simultaneously image intracellular Ca2+ and actin network 
dynamics in osteocytes in situ. ATP and ionomycin were used to biochemically-induce Ca2+ 
responses in osteocytes of ex vivo tibiae and confirm Ca2+-dependency of the contractile 
mechanism in both Fluo-8 + Lifeact and GCaMP3 + Lifeact osteocytes. Osteocytes from both 
mouse models exhibited Ca2+ oscillations and contractile events in response to whole-bone 
mechanical loading. In GCaMP3 + Lifeact mice, differential contractile responses were exhibited 
between increasing and decreasing loading sequences in individual osteocytes. This work 
improves our previously established protocol via a novel mouse model with targeted expression 
of fluorescent proteins to observe intracellular Ca2+ and actin dynamics of live osteocytes within 
the bone tissue immediately after tissue explant, as Ca2+ and contractile dynamics observed in 
response to ATP, ionomycin, and mechanical loading are similar to those observed in Fluo-8 AM 
+ Lifeact osteocytes. Using this model for improved real-time study of single cells in situ, this 
work is the first to demonstrate the mechanosensitivity of a Ca2+-dependent contractile 
mechanism in osteocytes, with both Ca2+ peaks and actin network contractions being enhanced 
with load magnitude. This Ca2+-dependent contractile mechanism may be a potential target for 





5.2 Future work 
 Overall, based on our success in observing mechanically-induced Ca2+ oscillations in 
osteocytes from ex vivo Dmp1-Cre;Ai38flx/flx;Lifeact mRFP+/- mice tibiae comparable to those 
demonstrated by Fluo-8 AM-dyed osteocytes, a logical next step would be to utilize Dmp1-
Cre;Ai38flx/flx mice in further studies of osteocyte Ca2+ signaling ex vivo. These mice would 
express the GCaMP3 Ca2+ indicator targeted specifically to osteocytes, eliminating limitations of 
Fluo-8 AM which include dye penetration depth and dye compartmentalization by cell metabolic 
processes during the loading and imaging period. This would also minimize experimental 
manipulation and incubation time of tibia samples, make it easier to perform Ca2+ signaling 
analyses in a more physiological manner. This condensed experimental timeline would most 
benefit the Scl-Ab studies in which sacrifice, dissection, and imaging of tibia samples from all 
treatment groups is ideally carried out in as short a time as possible. Additionally, the GCaMP3 
mouse model would be particularly beneficial when applied to the aged osteocyte 
mechanosensing studies and would help determine if the low number of cells analyzed in 
Chapter 2 is due to lower osteocyte density in the aged mice, rather than the impaired ability of 
aged osteocytes to take up and rapidly esterify Fluo-8. 
Given the diminished mechanosignaling properties in aged mice, it would be of interest 
to determine the mechanism responsible by using agonists for pathways that we know to be 
critical for sustaining load-induced Ca2+ oscillations, such as ATP. Furthermore, methods of 
preserving the osteocyte network as the mice age, either through pharmacological means or 
transgenic mouse models, would provide insight into the role of diminished osteocyte cell 
density and connectivity in maintaining and coordinating Ca2+ responses. The nature of the fluid 
flow in the lacunar-canalicular system (LCS) of aged osteocyte networks would also be an 
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interesting point for exploration through computational modeling, as fewer cells in the lacunae 
and reduced dendricity throughout the canaliculi may alter the fluid flow dynamics responsible 
for inducing osteocyte responses to whole-bone loading, including intracellular Ca2+. 
In further studies of Scl-Ab treatment, investigation of bone modeling and remodeling 
processes at the periosteum would strengthen the connection between rapid mineralization of 
osteocytes under short-term treatment and diminished mechanosensitivity of osteocyte Ca2+ 
signaling in the region of interest. This could be accomplished through temporal analyses of 
weekly in vivo micro-CT scans of the tibia anteromedial cortical bone surface. These micro-CT 
scans could also be used to generate computational finite element models, which could be used 
to support our experimental measures of anteromedial cortical bone strain. Identification of rapid 
modeling processes at the periosteum would confirm that the osteocytes visualized during cyclic 
loading and Ca2+ imaging are embedded as a result of the initial increase in bone formation 
response with short-term Scl-Ab treatment. Additionally, comparison of morphological 
characteristics of in situ osteocytes between treatment groups may provide some additional 
evidence for the differences in mechanosensitive potential observed in osteocytes from short-
term Scl-Ab treated animals. 
Based on our characterization of load-induced Ca2+ responses and downstream contractile 
events, future work would ideally be focused on probing points upstream and downstream of 
these mechanisms. Further study to determine relative contributions of mechanical loading and 
Ca2+ dynamics on actin contractions using actin stabilizing compounds and inhibitors of Ca2+ 
signaling would bring deeper understanding to this mechanism and its possible downstream 
contributions to bone formation processes. Additionally, investigating the contribution of 
mechanically-induced, Ca2+-dependent osteocyte contractions to the release of extracellular 
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vesicles in situ would confirm our previously-published in vitro findings and provide further 
evidence for extracellular vesicle release as a means of cell-cell communication in bone and a 
mechanism by which osteocytes direct bone formation processes. 
 
5.3 Significance 
 This broader impact of this body of work is the advancement in understanding of 
osteocyte mechanosensing in clinically-relevant contexts. It is thought the pathology of 
osteoporosis stems from impaired osteocyte mechanosensing and directing of bone resorption 
relative to formation. The studies in Chapter 2 provide, for the first time, a direct measure of this 
diminished mechanosensing in real time by comparing osteocyte Ca2+ signaling in tibia from 
aged and young-adult mice. With prior knowledge of the role of Ca2+ signaling in anabolic bone 
formation responses to load, dampened Ca2+ signaling in aged osteocytes may contribute to the 
dampened anabolic response to mechanical loading seen in longer-term, tissue-level studies. 
Previous work identifying the pathways responsible for load-induced Ca2+ signaling in 
osteocytes provides possible points of pharmacological agonist intervention to rescue the 
reduced mechanosignaling with aging. 
 While the effects of antibody to sclerostin, recently approved by the U.S. Food and Drug 
Administration as EVENITY™ for treatment of osteoporosis, on bone formation and resorption 
have been thoroughly characterized in animal studies as well as clinical trials, our work in 
Chapter 3 uncovers real-time mechanosensing measures in osteocytes from animals undergoing 
different treatment timelines. By showing that osteocyte mechanosensitivity is maintained in all 
treatment groups apart from strain-matched short-term treated samples, we demonstrate the 
distinct phases of the bone formation response to the drug at a cellular level. Having identified 
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diminished mechanosensing in newly-mineralized osteocytes, we now turn our attention to other 
possible Wnt antagonists or additional pathways responsible for self-regulation of the bone 
formation response, which may be addressed with supplemental therapies to EVENITY™. 
Ca2+-dependent contractility has been previously and thoroughly characterized in a 
variety of cell types. However, this mechanism has yet to be demonstrated in the osteocyte. This 
body of work not only confirms this common physiological mechanism for the first time in 
osteocytes in situ, but it provides evidence for the mechanosensitivity of Ca2+-dependent actin 
network contractions. Our work presents this mechanism as a potential link between osteocytes 
sensing mechanical loads and transducing changes in mechanical stimuli to bone effector cells 
such as osteoblasts and osteoclasts, therefore allowing for another point of intervention in 
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